<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns:m="http://schemas.microsoft.com/office/2004/12/omml"
xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 14">
<meta name=Originator content="Microsoft Word 14">
<link rel=File-List href="PMC2474852%20table%202_files/filelist.xml">
<link rel=Edit-Time-Data href="PMC2474852%20table%202_files/editdata.mso">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]-->
<link rel=themeData href="PMC2474852%20table%202_files/themedata.thmx">
<link rel=colorSchemeMapping
href="PMC2474852%20table%202_files/colorschememapping.xml">
<!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:Zoom>95</w:Zoom>
  <w:SpellingState>Clean</w:SpellingState>
  <w:GrammarState>Clean</w:GrammarState>
  <w:TrackMoves>false</w:TrackMoves>
  <w:TrackFormatting/>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotPromoteQF/>
  <w:LidThemeOther>EN-US</w:LidThemeOther>
  <w:LidThemeAsian>X-NONE</w:LidThemeAsian>
  <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
  <w:Compatibility>
   <w:BreakWrappedTables/>
   <w:SplitPgBreakAndParaMark/>
  </w:Compatibility>
  <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>
  <m:mathPr>
   <m:mathFont m:val="Cambria Math"/>
   <m:brkBin m:val="before"/>
   <m:brkBinSub m:val="&#45;-"/>
   <m:smallFrac m:val="off"/>
   <m:dispDef/>
   <m:lMargin m:val="0"/>
   <m:rMargin m:val="0"/>
   <m:defJc m:val="centerGroup"/>
   <m:wrapIndent m:val="1440"/>
   <m:intLim m:val="subSup"/>
   <m:naryLim m:val="undOvr"/>
  </m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"
  DefSemiHidden="true" DefQFormat="false" DefPriority="99"
  LatentStyleCount="267">
  <w:LsdException Locked="false" Priority="0" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Normal"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="heading 1"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="heading 2"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="heading 3"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 1"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 2"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 3"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 4"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 5"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 6"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 7"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 8"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 9"/>
  <w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/>
  <w:LsdException Locked="false" Priority="10" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Title"/>
  <w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/>
  <w:LsdException Locked="false" Priority="11" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/>
  <w:LsdException Locked="false" Priority="22" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Strong"/>
  <w:LsdException Locked="false" Priority="20" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/>
  <w:LsdException Locked="false" Priority="59" SemiHidden="false"
   UnhideWhenUsed="false" Name="Table Grid"/>
  <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/>
  <w:LsdException Locked="false" Priority="1" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 1"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/>
  <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/>
  <w:LsdException Locked="false" Priority="34" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/>
  <w:LsdException Locked="false" Priority="29" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Quote"/>
  <w:LsdException Locked="false" Priority="30" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 1"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 1"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 2"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 2"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 2"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 3"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 3"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 3"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 4"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 4"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 4"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 5"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 5"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 5"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 6"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 6"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 6"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="19" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/>
  <w:LsdException Locked="false" Priority="21" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/>
  <w:LsdException Locked="false" Priority="31" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/>
  <w:LsdException Locked="false" Priority="32" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/>
  <w:LsdException Locked="false" Priority="33" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Book Title"/>
  <w:LsdException Locked="false" Priority="37" Name="Bibliography"/>
  <w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading"/>
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Helvetica;
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536859905 -1073711037 9 0 511 0;}
@font-face
	{font-family:Helvetica;
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536859905 -1073711037 9 0 511 0;}
@font-face
	{font-family:"Arial Unicode MS";
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-134238209 -371195905 63 0 4129279 0;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1073786111 1 0 415 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-520081665 -1073717157 41 0 66047 0;}
@font-face
	{font-family:inherit;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:auto;
	mso-font-signature:0 0 0 0 0 0;}
@font-face
	{font-family:"\@Arial Unicode MS";
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-134238209 -371195905 63 0 4129279 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:10.0pt;
	margin-left:0in;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri","sans-serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	mso-bidi-font-family:"Times New Roman";}
h1
	{mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Heading 1 Char";
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	mso-outline-level:1;
	font-size:24.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	font-weight:bold;}
h2
	{mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Heading 2 Char";
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	mso-outline-level:2;
	font-size:18.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	font-weight:bold;}
h3
	{mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Heading 3 Char";
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	mso-outline-level:3;
	font-size:13.5pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	font-weight:bold;}
a:link, span.MsoHyperlink
	{mso-style-noshow:yes;
	mso-style-priority:99;
	color:blue;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{mso-style-noshow:yes;
	mso-style-priority:99;
	color:purple;
	text-decoration:underline;
	text-underline:single;}
p
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Balloon Text Char";
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:"Tahoma","sans-serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
span.Heading1Char
	{mso-style-name:"Heading 1 Char";
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Heading 1";
	font-family:"Times New Roman","serif";
	mso-ascii-font-family:"Times New Roman";
	mso-hansi-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	font-weight:bold;}
span.Heading2Char
	{mso-style-name:"Heading 2 Char";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Heading 2";
	font-family:"Times New Roman","serif";
	mso-ascii-font-family:"Times New Roman";
	mso-hansi-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	font-weight:bold;}
span.Heading3Char
	{mso-style-name:"Heading 3 Char";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Heading 3";
	font-family:"Times New Roman","serif";
	mso-ascii-font-family:"Times New Roman";
	mso-hansi-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	font-weight:bold;}
span.BalloonTextChar
	{mso-style-name:"Balloon Text Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Balloon Text";
	font-family:"Tahoma","sans-serif";
	mso-ascii-font-family:Tahoma;
	mso-hansi-font-family:Tahoma;
	mso-bidi-font-family:Tahoma;}
p.ui-button, li.ui-button, div.ui-button
	{mso-style-name:ui-button;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:1.2pt;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-spinner, li.ui-spinner, div.ui-spinner
	{mso-style-name:ui-spinner;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-spinner-input, li.ui-spinner-input, div.ui-spinner-input
	{mso-style-name:ui-spinner-input;
	mso-style-unhide:no;
	margin-top:2.4pt;
	margin-right:16.5pt;
	margin-bottom:2.4pt;
	margin-left:4.8pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-helper-hidden-accessible, li.ui-helper-hidden-accessible, div.ui-helper-hidden-accessible
	{mso-style-name:ui-helper-hidden-accessible;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:-.75pt;
	margin-bottom:0in;
	margin-left:-.75pt;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-buttonset, li.ui-buttonset, div.ui-buttonset
	{mso-style-name:ui-buttonset;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:5.25pt;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-datepicker, li.ui-datepicker, div.ui-datepicker
	{mso-style-name:ui-datepicker;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	display:none;
	mso-hide:all;}
p.ui-datepicker-row-break, li.ui-datepicker-row-break, div.ui-datepicker-row-break
	{mso-style-name:ui-datepicker-row-break;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:1.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-datepicker-rtl, li.ui-datepicker-rtl, div.ui-datepicker-rtl
	{mso-style-name:ui-datepicker-rtl;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:right;
	mso-pagination:widow-orphan;
	direction:rtl;
	unicode-bidi:embed;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-menu, li.ui-menu, div.ui-menu
	{mso-style-name:ui-menu;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-progressbar, li.ui-progressbar, div.ui-progressbar
	{mso-style-name:ui-progressbar;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-resizable-handle, li.ui-resizable-handle, div.ui-resizable-handle
	{mso-style-name:ui-resizable-handle;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:1.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-resizable-n, li.ui-resizable-n, div.ui-resizable-n
	{mso-style-name:ui-resizable-n;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-resizable-s, li.ui-resizable-s, div.ui-resizable-s
	{mso-style-name:ui-resizable-s;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-resizable-e, li.ui-resizable-e, div.ui-resizable-e
	{mso-style-name:ui-resizable-e;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-resizable-w, li.ui-resizable-w, div.ui-resizable-w
	{mso-style-name:ui-resizable-w;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-resizable-se, li.ui-resizable-se, div.ui-resizable-se
	{mso-style-name:ui-resizable-se;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-resizable-sw, li.ui-resizable-sw, div.ui-resizable-sw
	{mso-style-name:ui-resizable-sw;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-resizable-nw, li.ui-resizable-nw, div.ui-resizable-nw
	{mso-style-name:ui-resizable-nw;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-resizable-ne, li.ui-resizable-ne, div.ui-resizable-ne
	{mso-style-name:ui-resizable-ne;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-selectable-helper, li.ui-selectable-helper, div.ui-selectable-helper
	{mso-style-name:ui-selectable-helper;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-selectmenu-menu, li.ui-selectmenu-menu, div.ui-selectmenu-menu
	{mso-style-name:ui-selectmenu-menu;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	display:none;
	mso-hide:all;}
p.ui-selectmenu-open, li.ui-selectmenu-open, div.ui-selectmenu-open
	{mso-style-name:ui-selectmenu-open;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-selectmenu-button, li.ui-selectmenu-button, div.ui-selectmenu-button
	{mso-style-name:ui-selectmenu-button;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-slider, li.ui-slider, div.ui-slider
	{mso-style-name:ui-slider;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-slider-horizontal, li.ui-slider-horizontal, div.ui-slider-horizontal
	{mso-style-name:ui-slider-horizontal;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-slider-vertical, li.ui-slider-vertical, div.ui-slider-vertical
	{mso-style-name:ui-slider-vertical;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-spinner-button, li.ui-spinner-button, div.ui-spinner-button
	{mso-style-name:ui-spinner-button;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:6.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-tooltip, li.ui-tooltip, div.ui-tooltip
	{mso-style-name:ui-tooltip;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-state-default, li.ui-state-default, div.ui-state-default
	{mso-style-name:ui-state-default;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#E6E6E6;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#555555;}
p.ui-state-focus, li.ui-state-focus, div.ui-state-focus
	{mso-style-name:ui-state-focus;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#DADADA;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#212121;}
p.ui-state-hover, li.ui-state-hover, div.ui-state-hover
	{mso-style-name:ui-state-hover;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#DADADA;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#212121;}
p.ui-state-active, li.ui-state-active, div.ui-state-active
	{mso-style-name:ui-state-active;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#212121;}
p.ui-state-highlight, li.ui-state-highlight, div.ui-state-highlight
	{mso-style-name:ui-state-highlight;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#FBF9EE;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#363636;}
p.ui-state-error, li.ui-state-error, div.ui-state-error
	{mso-style-name:ui-state-error;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#FEF1EC;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#CD0A0A;}
p.ui-state-error-text, li.ui-state-error-text, div.ui-state-error-text
	{mso-style-name:ui-state-error-text;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#CD0A0A;}
p.ui-priority-primary, li.ui-priority-primary, div.ui-priority-primary
	{mso-style-name:ui-priority-primary;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	font-weight:bold;}
p.ui-priority-secondary, li.ui-priority-secondary, div.ui-priority-secondary
	{mso-style-name:ui-priority-secondary;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-state-disabled, li.ui-state-disabled, div.ui-state-disabled
	{mso-style-name:ui-state-disabled;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-helper-hidden, li.ui-helper-hidden, div.ui-helper-hidden
	{mso-style-name:ui-helper-hidden;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	display:none;
	mso-hide:all;}
p.ui-helper-reset, li.ui-helper-reset, div.ui-helper-reset
	{mso-style-name:ui-helper-reset;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-helper-zfix, li.ui-helper-zfix, div.ui-helper-zfix
	{mso-style-name:ui-helper-zfix;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-widget-overlay, li.ui-widget-overlay, div.ui-widget-overlay
	{mso-style-name:ui-widget-overlay;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#AAAAAA;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-helper-clearfix, li.ui-helper-clearfix, div.ui-helper-clearfix
	{mso-style-name:ui-helper-clearfix;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-icon, li.ui-icon, div.ui-icon
	{mso-style-name:ui-icon;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-indent:367.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-widget-content, li.ui-widget-content, div.ui-widget-content
	{mso-style-name:ui-widget-content;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#222222;}
p.ui-widget-header, li.ui-widget-header, div.ui-widget-header
	{mso-style-name:ui-widget-header;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#CCCCCC;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#222222;
	font-weight:bold;}
p.ui-widget-shadow, li.ui-widget-shadow, div.ui-widget-shadow
	{mso-style-name:ui-widget-shadow;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:-6.0pt;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	background:#AAAAAA;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-widget, li.ui-widget, div.ui-widget
	{mso-style-name:ui-widget;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Arial","sans-serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-tabs, li.ui-tabs, div.ui-tabs
	{mso-style-name:ui-tabs;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-dialog, li.ui-dialog, div.ui-dialog
	{mso-style-name:ui-dialog;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-dialog-titlebar, li.ui-dialog-titlebar, div.ui-dialog-titlebar
	{mso-style-name:ui-dialog-titlebar;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#3E72A6;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:white;}
p.ui-ncbiautocomplete-actions, li.ui-ncbiautocomplete-actions, div.ui-ncbiautocomplete-actions
	{mso-style-name:ui-ncbiautocomplete-actions;
	mso-style-unhide:no;
	margin-top:.75pt;
	margin-right:-.75pt;
	margin-bottom:0in;
	margin-left:-.75pt;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	background:#CECECE;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbiautocomplete-link-pref, li.ui-ncbiautocomplete-link-pref, div.ui-ncbiautocomplete-link-pref
	{mso-style-name:ui-ncbiautocomplete-link-pref;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-indent:-945.65pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbibutton, li.ui-ncbibutton, div.ui-ncbibutton
	{mso-style-name:ui-ncbibutton;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:1.2pt;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:inherit;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	mso-bidi-font-family:"Times New Roman";}
p.ui-button-icon-only, li.ui-button-icon-only, div.ui-button-icon-only
	{mso-style-name:ui-button-icon-only;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-button-icons-only, li.ui-button-icons-only, div.ui-button-icons-only
	{mso-style-name:ui-button-icons-only;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbigrid-outer-div, li.ui-ncbigrid-outer-div, div.ui-ncbigrid-outer-div
	{mso-style-name:ui-ncbigrid-outer-div;
	mso-style-unhide:no;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:33.6pt;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbigrid-inner-div, li.ui-ncbigrid-inner-div, div.ui-ncbigrid-inner-div
	{mso-style-name:ui-ncbigrid-inner-div;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbigrid-filter-toolbar, li.ui-ncbigrid-filter-toolbar, div.ui-ncbigrid-filter-toolbar
	{mso-style-name:ui-ncbigrid-filter-toolbar;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:right;
	line-height:20.25pt;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbigrid-paged-toolbar, li.ui-ncbigrid-paged-toolbar, div.ui-ncbigrid-paged-toolbar
	{mso-style-name:ui-ncbigrid-paged-toolbar;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	line-height:19.4pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbigrid-checkbox-toolbar, li.ui-ncbigrid-checkbox-toolbar, div.ui-ncbigrid-checkbox-toolbar
	{mso-style-name:ui-ncbigrid-checkbox-toolbar;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	line-height:21.0pt;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbigrid-paged-countitems, li.ui-ncbigrid-paged-countitems, div.ui-ncbigrid-paged-countitems
	{mso-style-name:ui-ncbigrid-paged-countitems;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbigrid-paged-pagecontrol, li.ui-ncbigrid-paged-pagecontrol, div.ui-ncbigrid-paged-pagecontrol
	{mso-style-name:ui-ncbigrid-paged-pagecontrol;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:right;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbigrid-paged-toolbar-bottom, li.ui-ncbigrid-paged-toolbar-bottom, div.ui-ncbigrid-paged-toolbar-bottom
	{mso-style-name:ui-ncbigrid-paged-toolbar-bottom;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbigrid-select-question, li.ui-ncbigrid-select-question, div.ui-ncbigrid-select-question
	{mso-style-name:ui-ncbigrid-select-question;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	display:none;
	mso-hide:all;}
p.ui-ncbigrid-select-question-footer, li.ui-ncbigrid-select-question-footer, div.ui-ncbigrid-select-question-footer
	{mso-style-name:ui-ncbigrid-select-question-footer;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbibasicmenu, li.ui-ncbibasicmenu, div.ui-ncbibasicmenu
	{mso-style-name:ui-ncbibasicmenu;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbibasicmenuli, li.ui-ncbibasicmenuli, div.ui-ncbibasicmenuli
	{mso-style-name:ui-ncbibasicmenu>li;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.orientationhortli, li.orientationhortli, div.orientationhortli
	{mso-style-name:orientation_hort>li;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.jig-ncbimenu, li.jig-ncbimenu, div.jig-ncbimenu
	{mso-style-name:jig-ncbimenu;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.jig-ncbimenuli, li.jig-ncbimenuli, div.jig-ncbimenuli
	{mso-style-name:jig-ncbimenu>li;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbipopper-wrapper, li.ui-ncbipopper-wrapper, div.ui-ncbipopper-wrapper
	{mso-style-name:ui-ncbipopper-wrapper;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	display:none;
	mso-hide:all;}
p.ui-ncbipopper-basic, li.ui-ncbipopper-basic, div.ui-ncbipopper-basic
	{mso-style-name:ui-ncbipopper-basic;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#303030;}
p.brieflinkpopdesc, li.brieflinkpopdesc, div.brieflinkpopdesc
	{mso-style-name:brieflinkpopdesc;
	mso-style-unhide:no;
	margin-top:4.8pt;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbitoggler-slave, li.ui-ncbitoggler-slave, div.ui-ncbitoggler-slave
	{mso-style-name:ui-ncbitoggler-slave;
	mso-style-unhide:no;
	margin-top:2.4pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:12.0pt;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	display:none;
	mso-hide:all;}
p.ui-ncbitoggler-slave-open, li.ui-ncbitoggler-slave-open, div.ui-ncbitoggler-slave-open
	{mso-style-name:ui-ncbitoggler-slave-open;
	mso-style-unhide:no;
	margin-top:2.4pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:12.0pt;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbilinksmenu, li.ui-ncbilinksmenu, div.ui-ncbilinksmenu
	{mso-style-name:ui-ncbilinksmenu;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#FCFCFC;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#999999;
	font-weight:bold;}
p.ui-ncbilinksmenu-loadingmessage, li.ui-ncbilinksmenu-loadingmessage, div.ui-ncbilinksmenu-loadingmessage
	{mso-style-name:ui-ncbilinksmenu-loadingmessage;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbiclearbutton-wrap, li.ui-ncbiclearbutton-wrap, div.ui-ncbiclearbutton-wrap
	{mso-style-name:ui-ncbiclearbutton-wrap;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbiexpander, li.ui-ncbiexpander, div.ui-ncbiexpander
	{mso-style-name:ui-ncbiexpander;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbiexpander-simple, li.ui-ncbiexpander-simple, div.ui-ncbiexpander-simple
	{mso-style-name:ui-ncbiexpander-simple;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-expander-arrow-bar, li.ui-expander-arrow-bar, div.ui-expander-arrow-bar
	{mso-style-name:ui-expander-arrow-bar;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-expander-controllink, li.ui-expander-controllink, div.ui-expander-controllink
	{mso-style-name:ui-expander-controllink;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.jig-ncbiinpagenav-goto-container, li.jig-ncbiinpagenav-goto-container, div.jig-ncbiinpagenav-goto-container
	{mso-style-name:jig-ncbiinpagenav-goto-container;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:right;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbisetswitch, li.ui-ncbisetswitch, div.ui-ncbisetswitch
	{mso-style-name:ui-ncbisetswitch;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#F6F6F6;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#444444;}
p.ui-ncbisetswitch-hasstar, li.ui-ncbisetswitch-hasstar, div.ui-ncbisetswitch-hasstar
	{mso-style-name:ui-ncbisetswitch-hasstar;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.fg-button-icon-left, li.fg-button-icon-left, div.fg-button-icon-left
	{mso-style-name:fg-button-icon-left;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.jig-ncbihistogram, li.jig-ncbihistogram, div.jig-ncbihistogram
	{mso-style-name:jig-ncbihistogram;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbihistogram, li.ui-ncbihistogram, div.ui-ncbihistogram
	{mso-style-name:ui-ncbihistogram;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbihistogram-display-area, li.ui-ncbihistogram-display-area, div.ui-ncbihistogram-display-area
	{mso-style-name:ui-ncbihistogram-display-area;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbihistogram-display-areaollih3, li.ui-ncbihistogram-display-areaollih3, div.ui-ncbihistogram-display-areaollih3
	{mso-style-name:ui-ncbihistogram-display-area>ol>li>h3;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	text-indent:366.4pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbihistogram-controls, li.ui-ncbihistogram-controls, div.ui-ncbihistogram-controls
	{mso-style-name:ui-ncbihistogram-controls;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbihistogram-left, li.ui-ncbihistogram-left, div.ui-ncbihistogram-left
	{mso-style-name:ui-ncbihistogram-left;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:2.25pt;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:1.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbihistogram-right, li.ui-ncbihistogram-right, div.ui-ncbihistogram-right
	{mso-style-name:ui-ncbihistogram-right;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:2.25pt;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:1.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbihistogram-left-disabled, li.ui-ncbihistogram-left-disabled, div.ui-ncbihistogram-left-disabled
	{mso-style-name:ui-ncbihistogram-left-disabled;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#DDDDDD;}
p.ui-ncbihistogram-right-disabled, li.ui-ncbihistogram-right-disabled, div.ui-ncbihistogram-right-disabled
	{mso-style-name:ui-ncbihistogram-right-disabled;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#DDDDDD;}
p.ui-ncbihistogram-text, li.ui-ncbihistogram-text, div.ui-ncbihistogram-text
	{mso-style-name:ui-ncbihistogram-text;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:12.75pt;
	margin-bottom:0in;
	margin-left:12.75pt;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:21.8pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbihistogram-tooltip, li.ui-ncbihistogram-tooltip, div.ui-ncbihistogram-tooltip
	{mso-style-name:ui-ncbihistogram-tooltip;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:black;
	display:none;
	mso-hide:all;}
p.ncbiactivevalidationmsg, li.ncbiactivevalidationmsg, div.ncbiactivevalidationmsg
	{mso-style-name:ncbiactivevalidation_msg;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ncbiactivevalidationmsgchecking, li.ncbiactivevalidationmsgchecking, div.ncbiactivevalidationmsgchecking
	{mso-style-name:ncbiactivevalidation_msg_checking;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#FF9900;}
p.ncbiactivevalidationmsgvalid, li.ncbiactivevalidationmsgvalid, div.ncbiactivevalidationmsgvalid
	{mso-style-name:ncbiactivevalidation_msg_valid;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:green;}
p.ncbiactivevalidationmsgerror, li.ncbiactivevalidationmsgerror, div.ncbiactivevalidationmsgerror
	{mso-style-name:ncbiactivevalidation_msg_error;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:red;}
p.ncbiactivevalidationmsginfo, li.ncbiactivevalidationmsginfo, div.ncbiactivevalidationmsginfo
	{mso-style-name:ncbiactivevalidation_msg_info;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:blue;}
p.ncbiactivevalidationelerror, li.ncbiactivevalidationelerror, div.ncbiactivevalidationelerror
	{mso-style-name:ncbiactivevalidation_el_error;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.social-buttons, li.social-buttons, div.social-buttons
	{mso-style-name:social-buttons;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	margin-bottom:12.0pt;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.inlinelist, li.inlinelist, div.inlinelist
	{mso-style-name:inline_list;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.inline, li.inline, div.inline
	{mso-style-name:inline;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.fig, li.fig, div.fig
	{mso-style-name:fig;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.table, li.table, div.table
	{mso-style-name:table;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.pmc-wm, li.pmc-wm, div.pmc-wm
	{mso-style-name:pmc-wm;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.attic, li.attic, div.attic
	{mso-style-name:attic;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#336699;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.basement, li.basement, div.basement
	{mso-style-name:basement;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#336699;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.page-breadcrumbs, li.page-breadcrumbs, div.page-breadcrumbs
	{mso-style-name:page-breadcrumbs;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Arial","sans-serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.first-line-outdent, li.first-line-outdent, div.first-line-outdent
	{mso-style-name:first-line-outdent;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.vatop, li.vatop, div.vatop
	{mso-style-name:va_top;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.vamiddle, li.vamiddle, div.vamiddle
	{mso-style-name:va_middle;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.qtrhythm, li.qtrhythm, div.qtrhythm
	{mso-style-name:qt_rhythm;
	mso-style-unhide:no;
	margin-top:4.15pt;
	margin-right:0in;
	margin-bottom:4.15pt;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.notopmargin, li.notopmargin, div.notopmargin
	{mso-style-name:no_top_margin;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.nobottommargin, li.nobottommargin, div.nobottommargin
	{mso-style-name:no_bottom_margin;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.tscanvas, li.tscanvas, div.tscanvas
	{mso-style-name:ts_canvas;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.tsbar, li.tsbar, div.tsbar
	{mso-style-name:ts_bar;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	background:#DCF0F4;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.fm-reuse, li.fm-reuse, div.fm-reuse
	{mso-style-name:fm-reuse;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:.5in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.fm-subtitle, li.fm-subtitle, div.fm-subtitle
	{mso-style-name:fm-subtitle;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:15.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.fm-copyright-license, li.fm-copyright-license, div.fm-copyright-license
	{mso-style-name:fm-copyright-license;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.fm-citation-from, li.fm-citation-from, div.fm-citation-from
	{mso-style-name:fm-citation-from;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ft-thumb-box, li.ft-thumb-box, div.ft-thumb-box
	{mso-style-name:ft-thumb-box;
	mso-style-unhide:no;
	margin:8.3pt;
	text-align:center;
	mso-pagination:widow-orphan;
	background:#F8F8F8;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ft-thumb-current, li.ft-thumb-current, div.ft-thumb-current
	{mso-style-name:ft-thumb-current;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#D0DCE8;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.tab, li.tab, div.tab
	{mso-style-name:tab;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	background:#F8F8F8;
	font-size:12.0pt;
	font-family:"Arial","sans-serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.arrowtab, li.arrowtab, div.arrowtab
	{mso-style-name:arrowtab;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	background:#F8F8F8;
	font-size:12.0pt;
	font-family:"Arial","sans-serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.blanktab, li.blanktab, div.blanktab
	{mso-style-name:blanktab;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	background:#F8F8F8;
	font-size:12.0pt;
	font-family:"Arial","sans-serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.thistab, li.thistab, div.thistab
	{mso-style-name:thistab;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	background:white;
	font-size:12.0pt;
	font-family:"Arial","sans-serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	font-weight:bold;}
p.doi, li.doi, div.doi
	{mso-style-name:doi;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.msg-error, li.msg-error, div.msg-error
	{mso-style-name:msg-error;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:yellow;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:red;}
p.msg-warning, li.msg-warning, div.msg-warning
	{mso-style-name:msg-warning;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:yellow;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:brown;}
p.nihms-highlight, li.nihms-highlight, div.nihms-highlight
	{mso-style-name:nihms-highlight;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:2.4pt;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:center;
	mso-pagination:widow-orphan;
	background:yellow;
	font-size:10.5pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#990000;}
p.head, li.head, div.head
	{mso-style-name:head;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.sub-head, li.sub-head, div.sub-head
	{mso-style-name:sub-head;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.headless, li.headless, div.headless
	{mso-style-name:headless;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.sub-navigation, li.sub-navigation, div.sub-navigation
	{mso-style-name:sub-navigation;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.sec, li.sec, div.sec
	{mso-style-name:sec;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.content-branding, li.content-branding, div.content-branding
	{mso-style-name:content-branding;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.banner-generic-logo-background, li.banner-generic-logo-background, div.banner-generic-logo-background
	{mso-style-name:banner-generic-logo-background;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:silver;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:white;}
p.banner-journal-name, li.banner-journal-name, div.banner-journal-name
	{mso-style-name:banner-journal-name;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:20.5pt;
	font-family:"Calibri","sans-serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	mso-bidi-font-family:"Times New Roman";
	font-variant:small-caps;
	letter-spacing:.3pt;}
p.banner-journal-publisher-over-image, li.banner-journal-publisher-over-image, div.banner-journal-publisher-over-image
	{mso-style-name:banner-journal-publisher-over-image;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:7.5pt;
	mso-margin-bottom-alt:auto;
	margin-left:63.0pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.banner-publisher-name, li.banner-publisher-name, div.banner-publisher-name
	{mso-style-name:banner-publisher-name;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:right;
	mso-pagination:widow-orphan;
	font-size:9.5pt;
	font-family:"Calibri","sans-serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	mso-bidi-font-family:"Times New Roman";
	color:#AA1111;
	font-weight:bold;}
p.bl-w-jtitle-over, li.bl-w-jtitle-over, div.bl-w-jtitle-over
	{mso-style-name:bl-w-jtitle-over;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:18.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	font-variant:small-caps;}
p.bl-w-jtitle-over-ph, li.bl-w-jtitle-over-ph, div.bl-w-jtitle-over-ph
	{mso-style-name:bl-w-jtitle-over-ph;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.bl-w-jtitle-over-ph-content, li.bl-w-jtitle-over-ph-content, div.bl-w-jtitle-over-ph-content
	{mso-style-name:bl-w-jtitle-over-ph-content;
	mso-style-unhide:no;
	margin-top:3.0pt;
	margin-right:6.0pt;
	margin-bottom:3.0pt;
	margin-left:78.75pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.banner-journal-publisher-over-image-elsevierwt, li.banner-journal-publisher-over-image-elsevierwt, div.banner-journal-publisher-over-image-elsevierwt
	{mso-style-name:banner-journal-publisher-over-image-elsevierwt;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:120.0pt;
	margin-bottom:0in;
	margin-left:15.0pt;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.elsevierwt-sponsored-label, li.elsevierwt-sponsored-label, div.elsevierwt-sponsored-label
	{mso-style-name:elsevierwt-sponsored-label;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:-9.0pt;
	line-height:13.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Calibri","sans-serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	mso-bidi-font-family:"Times New Roman";
	font-variant:small-caps;
	letter-spacing:.9pt;
	font-style:italic;}
p.bl-jtitle-sageopen, li.bl-jtitle-sageopen, div.bl-jtitle-sageopen
	{mso-style-name:bl-jtitle-sageopen;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#0055A5;}
p.bl-jtitle-iospressopenlib, li.bl-jtitle-iospressopenlib, div.bl-jtitle-iospressopenlib
	{mso-style-name:bl-jtitle-iospressopenlib;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:white;}
p.bl-jtitle-apasd, li.bl-jtitle-apasd, div.bl-jtitle-apasd
	{mso-style-name:bl-jtitle-apasd;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#1E73B3;}
p.bl-jtitle-springeropen, li.bl-jtitle-springeropen, div.bl-jtitle-springeropen
	{mso-style-name:bl-jtitle-springeropen;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#F0F0F0;}
p.bl-jtitle-sfesd, li.bl-jtitle-sfesd, div.bl-jtitle-sfesd
	{mso-style-name:bl-jtitle-sfesd;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:white;}
p.bl-jtitle-acssd, li.bl-jtitle-acssd, div.bl-jtitle-acssd
	{mso-style-name:bl-jtitle-acssd;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#1E73B3;}
p.bl-jtitle-esesd, li.bl-jtitle-esesd, div.bl-jtitle-esesd
	{mso-style-name:bl-jtitle-esesd;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	line-height:33.75pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.bl-jtitle-srfsd, li.bl-jtitle-srfsd, div.bl-jtitle-srfsd
	{mso-style-name:bl-jtitle-srfsd;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	line-height:33.75pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.bl-jtitle-tea, li.bl-jtitle-tea, div.bl-jtitle-tea
	{mso-style-name:bl-jtitle-tea;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:right;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#861316;}
p.bl-jtitle-rcpsychsd, li.bl-jtitle-rcpsychsd, div.bl-jtitle-rcpsychsd
	{mso-style-name:bl-jtitle-rcpsychsd;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#44448A;}
p.bl-jtitle-npgopen, li.bl-jtitle-npgopen, div.bl-jtitle-npgopen
	{mso-style-name:bl-jtitle-npgopen;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:white;}
p.bl-jtitle-maneyopen, li.bl-jtitle-maneyopen, div.bl-jtitle-maneyopen
	{mso-style-name:bl-jtitle-maneyopen;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:white;}
p.bl-jtitle-bmjgroup, li.bl-jtitle-bmjgroup, div.bl-jtitle-bmjgroup
	{mso-style-name:bl-jtitle-bmjgroup;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#003366;}
p.bl-jtitle-clpt, li.bl-jtitle-clpt, div.bl-jtitle-clpt
	{mso-style-name:bl-jtitle-clpt;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:white;}
p.bl-jtitle-nihpa-wiley, li.bl-jtitle-nihpa-wiley, div.bl-jtitle-nihpa-wiley
	{mso-style-name:bl-jtitle-nihpa-wiley;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:white;}
p.bl-jtitle-rsmsd, li.bl-jtitle-rsmsd, div.bl-jtitle-rsmsd
	{mso-style-name:bl-jtitle-rsmsd;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:white;}
p.bl-jtitle-hogrefesd, li.bl-jtitle-hogrefesd, div.bl-jtitle-hogrefesd
	{mso-style-name:bl-jtitle-hogrefesd;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#025490;}
p.mp-outer, li.mp-outer, div.mp-outer
	{mso-style-name:mp-outer;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.mp-outerdiv, li.mp-outerdiv, div.mp-outerdiv
	{mso-style-name:mp-outer>div;
	mso-style-unhide:no;
	margin:1.5pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.toc-highlight1, li.toc-highlight1, div.toc-highlight1
	{mso-style-name:toc-highlight1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#FFFFD0;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.toc-highlight2, li.toc-highlight2, div.toc-highlight2
	{mso-style-name:toc-highlight2;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#ACE4FF;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.toc-hl-inaugural, li.toc-hl-inaugural, div.toc-hl-inaugural
	{mso-style-name:toc-hl-inaugural;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#E64A00;}
p.courtesy-note, li.courtesy-note, div.courtesy-note
	{mso-style-name:courtesy-note;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Arial","sans-serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.Footer1, li.Footer1, div.Footer1
	{mso-style-name:Footer1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.suppmat, li.suppmat, div.suppmat
	{mso-style-name:suppmat;
	mso-style-unhide:no;
	margin-top:8.3pt;
	margin-right:0in;
	margin-bottom:8.3pt;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.aligncenter, li.aligncenter, div.aligncenter
	{mso-style-name:align_center;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.mul-switcher, li.mul-switcher, div.mul-switcher
	{mso-style-name:mul-switcher;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:right;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.Strong1, li.Strong1, div.Strong1
	{mso-style-name:Strong1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	font-weight:bold;}
p.red, li.red, div.red
	{mso-style-name:red;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:red;}
p.navigator, li.navigator, div.navigator
	{mso-style-name:navigator;
	mso-style-unhide:no;
	margin-top:15.0pt;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	background:#F6F6F6;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.summary, li.summary, div.summary
	{mso-style-name:summary;
	mso-style-unhide:no;
	margin-top:15.0pt;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.head1a, li.head1a, div.head1a
	{mso-style-name:head1a;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.navigator-header, li.navigator-header, div.navigator-header
	{mso-style-name:navigator-header;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.navigator-footer, li.navigator-footer, div.navigator-footer
	{mso-style-name:navigator-footer;
	mso-style-unhide:no;
	margin-top:7.5pt;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.navigator-bar, li.navigator-bar, div.navigator-bar
	{mso-style-name:navigator-bar;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.navigator-page, li.navigator-page, div.navigator-page
	{mso-style-name:navigator-page;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.navigator-bar-table, li.navigator-bar-table, div.navigator-bar-table
	{mso-style-name:navigator-bar-table;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.section-with-images-on-the-same-page, li.section-with-images-on-the-same-page, div.section-with-images-on-the-same-page
	{mso-style-name:section-with-images-on-the-same-page;
	mso-style-unhide:no;
	margin-top:15.0pt;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.main-archive-list-of-volumes, li.main-archive-list-of-volumes, div.main-archive-list-of-volumes
	{mso-style-name:main-archive-list-of-volumes;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.archive-header, li.archive-header, div.archive-header
	{mso-style-name:archive-header;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	margin-bottom:7.5pt;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	font-weight:bold;}
p.journal-block-title, li.journal-block-title, div.journal-block-title
	{mso-style-name:journal-block-title;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	background:#CCD8E4;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:black;
	font-weight:bold;}
p.vol-year-cell, li.vol-year-cell, div.vol-year-cell
	{mso-style-name:vol-year-cell;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	background:#CCD8E4;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:black;
	font-weight:bold;}
p.issue-block, li.issue-block, div.issue-block
	{mso-style-name:issue-block;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#8CACCC;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.iss-dark-row, li.iss-dark-row, div.iss-dark-row
	{mso-style-name:iss-dark-row;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#EFF1F3;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.iss-light-row, li.iss-light-row, div.iss-light-row
	{mso-style-name:iss-light-row;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.iss-cell, li.iss-cell, div.iss-cell
	{mso-style-name:iss-cell;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.vol-cell, li.vol-cell, div.vol-cell
	{mso-style-name:vol-cell;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.arc-issue, li.arc-issue, div.arc-issue
	{mso-style-name:arc-issue;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#0055AA;}
p.large-thumb-canvas, li.large-thumb-canvas, div.large-thumb-canvas
	{mso-style-name:large-thumb-canvas;
	mso-style-unhide:no;
	margin:8.5pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#444444;
	display:none;
	mso-hide:all;}
p.co, li.co, div.co
	{mso-style-name:co;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	display:none;
	mso-hide:all;}
p.co-default, li.co-default, div.co-default
	{mso-style-name:co-default;
	mso-style-unhide:no;
	margin:8.5pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#444444;}
p.large-thumb-canvas-1, li.large-thumb-canvas-1, div.large-thumb-canvas-1
	{mso-style-name:large-thumb-canvas-1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.co-inner, li.co-inner, div.co-inner
	{mso-style-name:co-inner;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.in-progress, li.in-progress, div.in-progress
	{mso-style-name:in-progress;
	mso-style-unhide:no;
	margin:1.5pt;
	mso-pagination:widow-orphan;
	background:#444444;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.large-thumb, li.large-thumb, div.large-thumb
	{mso-style-name:large-thumb;
	mso-style-unhide:no;
	margin:1.5pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	display:none;
	mso-hide:all;}
p.small-thumb-canvas, li.small-thumb-canvas, div.small-thumb-canvas
	{mso-style-name:small-thumb-canvas;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.small-thumb, li.small-thumb, div.small-thumb
	{mso-style-name:small-thumb;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.figpopup-sensitive-area, li.figpopup-sensitive-area, div.figpopup-sensitive-area
	{mso-style-name:figpopup-sensitive-area;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.print-view, li.print-view, div.print-view
	{mso-style-name:print-view;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.citationexporter-header, li.citationexporter-header, div.citationexporter-header
	{mso-style-name:citationexporter-header;
	mso-style-unhide:no;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:12.0pt;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	font-style:italic;}
p.citationexporter-footer, li.citationexporter-footer, div.citationexporter-footer
	{mso-style-name:citationexporter-footer;
	mso-style-unhide:no;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:12.0pt;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.mathjaxpreview, li.mathjaxpreview, div.mathjaxpreview
	{mso-style-name:mathjax_preview;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#888888;}
p.mathjaxerror, li.mathjaxerror, div.mathjaxerror
	{mso-style-name:mathjax_error;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#CC0000;
	font-style:italic;}
p.mathjaxmenu, li.mathjaxmenu, div.mathjaxmenu
	{mso-style-name:mathjax_menu;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:black;}
p.mathjaxmenuitem, li.mathjaxmenuitem, div.mathjaxmenuitem
	{mso-style-name:mathjax_menuitem;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.mathjaxmenuarrow, li.mathjaxmenuarrow, div.mathjaxmenuarrow
	{mso-style-name:mathjax_menuarrow;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:"Arial Unicode MS","sans-serif";
	color:#666666;}
p.mathjaxmenucheck, li.mathjaxmenucheck, div.mathjaxmenucheck
	{mso-style-name:mathjax_menucheck;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Arial Unicode MS","sans-serif";}
p.mathjaxmenulabel, li.mathjaxmenulabel, div.mathjaxmenulabel
	{mso-style-name:mathjax_menulabel;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	font-style:italic;}
p.mathjaxmenurule, li.mathjaxmenurule, div.mathjaxmenurule
	{mso-style-name:mathjax_menurule;
	mso-style-unhide:no;
	margin-top:3.0pt;
	margin-right:.75pt;
	margin-bottom:0in;
	margin-left:.75pt;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.mathjaxmenuclose, li.mathjaxmenuclose, div.mathjaxmenuclose
	{mso-style-name:mathjax_menuclose;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:18.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#F0F0F0;}
p.print-log, li.print-log, div.print-log
	{mso-style-name:print-log;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-accordion-header, li.ui-accordion-header, div.ui-accordion-header
	{mso-style-name:ui-accordion-header;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-accordion-icons, li.ui-accordion-icons, div.ui-accordion-icons
	{mso-style-name:ui-accordion-icons;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-accordion-content, li.ui-accordion-content, div.ui-accordion-content
	{mso-style-name:ui-accordion-content;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-button-text, li.ui-button-text, div.ui-button-text
	{mso-style-name:ui-button-text;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-datepicker-header, li.ui-datepicker-header, div.ui-datepicker-header
	{mso-style-name:ui-datepicker-header;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-datepicker-next, li.ui-datepicker-next, div.ui-datepicker-next
	{mso-style-name:ui-datepicker-next;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-datepicker-prev, li.ui-datepicker-prev, div.ui-datepicker-prev
	{mso-style-name:ui-datepicker-prev;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-datepicker-title, li.ui-datepicker-title, div.ui-datepicker-title
	{mso-style-name:ui-datepicker-title;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-datepicker-buttonpane, li.ui-datepicker-buttonpane, div.ui-datepicker-buttonpane
	{mso-style-name:ui-datepicker-buttonpane;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-datepicker-group, li.ui-datepicker-group, div.ui-datepicker-group
	{mso-style-name:ui-datepicker-group;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-dialog-title, li.ui-dialog-title, div.ui-dialog-title
	{mso-style-name:ui-dialog-title;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-dialog-buttonpane, li.ui-dialog-buttonpane, div.ui-dialog-buttonpane
	{mso-style-name:ui-dialog-buttonpane;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-menu-item, li.ui-menu-item, div.ui-menu-item
	{mso-style-name:ui-menu-item;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-menu-divider, li.ui-menu-divider, div.ui-menu-divider
	{mso-style-name:ui-menu-divider;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-progressbar-value, li.ui-progressbar-value, div.ui-progressbar-value
	{mso-style-name:ui-progressbar-value;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-progressbar-overlay, li.ui-progressbar-overlay, div.ui-progressbar-overlay
	{mso-style-name:ui-progressbar-overlay;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-slider-handle, li.ui-slider-handle, div.ui-slider-handle
	{mso-style-name:ui-slider-handle;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-slider-range, li.ui-slider-range, div.ui-slider-range
	{mso-style-name:ui-slider-range;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-tabs-nav, li.ui-tabs-nav, div.ui-tabs-nav
	{mso-style-name:ui-tabs-nav;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-tabs-panel, li.ui-tabs-panel, div.ui-tabs-panel
	{mso-style-name:ui-tabs-panel;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-tabs-hide, li.ui-tabs-hide, div.ui-tabs-hide
	{mso-style-name:ui-tabs-hide;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-dialog-titlebar-close, li.ui-dialog-titlebar-close, div.ui-dialog-titlebar-close
	{mso-style-name:ui-dialog-titlebar-close;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-dialog-content, li.ui-dialog-content, div.ui-dialog-content
	{mso-style-name:ui-dialog-content;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbiautocomplete-link-pref-right, li.ui-ncbiautocomplete-link-pref-right, div.ui-ncbiautocomplete-link-pref-right
	{mso-style-name:ui-ncbiautocomplete-link-pref-right;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-button-icon-primary, li.ui-button-icon-primary, div.ui-button-icon-primary
	{mso-style-name:ui-button-icon-primary;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-button-icon-secondary, li.ui-button-icon-secondary, div.ui-button-icon-secondary
	{mso-style-name:ui-button-icon-secondary;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.prev, li.prev, div.prev
	{mso-style-name:prev;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.next, li.next, div.next
	{mso-style-name:next;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbigrid-select-row-count, li.ui-ncbigrid-select-row-count, div.ui-ncbigrid-select-row-count
	{mso-style-name:ui-ncbigrid-select-row-count;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbibasicmenulia, li.ui-ncbibasicmenulia, div.ui-ncbibasicmenulia
	{mso-style-name:ui-ncbibasicmenu>li>a;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbimenu-item-leaf, li.ui-ncbimenu-item-leaf, div.ui-ncbimenu-item-leaf
	{mso-style-name:ui-ncbimenu-item-leaf;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.brieflinkpop, li.brieflinkpop, div.brieflinkpop
	{mso-style-name:brieflinkpop;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.star, li.star, div.star
	{mso-style-name:star;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.jig-ncbisetswitch, li.jig-ncbisetswitch, div.jig-ncbisetswitch
	{mso-style-name:jig-ncbisetswitch;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbisetswitch-button, li.ui-ncbisetswitch-button, div.ui-ncbisetswitch-button
	{mso-style-name:ui-ncbisetswitch-button;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbisetswitch-options, li.ui-ncbisetswitch-options, div.ui-ncbisetswitch-options
	{mso-style-name:ui-ncbisetswitch-options;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.boxed-text-box, li.boxed-text-box, div.boxed-text-box
	{mso-style-name:boxed-text-box;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.cell-from, li.cell-from, div.cell-from
	{mso-style-name:cell-from;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.cell-citation, li.cell-citation, div.cell-citation
	{mso-style-name:cell-citation;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.figpopup, li.figpopup, div.figpopup
	{mso-style-name:figpopup;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.button, li.button, div.button
	{mso-style-name:button;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.retraction, li.retraction, div.retraction
	{mso-style-name:retraction;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.mathjaxhoverarrow, li.mathjaxhoverarrow, div.mathjaxhoverarrow
	{mso-style-name:mathjax_hover_arrow;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.pbody, li.pbody, div.pbody
	{mso-style-name:pbody;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.page-box, li.page-box, div.page-box
	{mso-style-name:page-box;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.page-box-wide, li.page-box-wide, div.page-box-wide
	{mso-style-name:page-box-wide;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.nomaxwidth, li.nomaxwidth, div.nomaxwidth
	{mso-style-name:no_max_width;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.f, li.f, div.f
	{mso-style-name:f;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.l, li.l, div.l
	{mso-style-name:l;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-accordion-header-icon, li.ui-accordion-header-icon, div.ui-accordion-header-icon
	{mso-style-name:ui-accordion-header-icon;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-selectmenu-optgroup, li.ui-selectmenu-optgroup, div.ui-selectmenu-optgroup
	{mso-style-name:ui-selectmenu-optgroup;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-tabs-anchor, li.ui-tabs-anchor, div.ui-tabs-anchor
	{mso-style-name:ui-tabs-anchor;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbibutton-submit, li.ui-ncbibutton-submit, div.ui-ncbibutton-submit
	{mso-style-name:ui-ncbibutton-submit;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbibutton-cancel, li.ui-ncbibutton-cancel, div.ui-ncbibutton-cancel
	{mso-style-name:ui-ncbibutton-cancel;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ltd-hover, li.ltd-hover, div.ltd-hover
	{mso-style-name:ltd-hover;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.warn, li.warn, div.warn
	{mso-style-name:warn;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.notice, li.notice, div.notice
	{mso-style-name:notice;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.content, li.content, div.content
	{mso-style-name:content;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.onelinesource, li.onelinesource, div.onelinesource
	{mso-style-name:one_line_source;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.tertiary, li.tertiary, div.tertiary
	{mso-style-name:tertiary;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.mathjaxhoverframe, li.mathjaxhoverframe, div.mathjaxhoverframe
	{mso-style-name:mathjax_hover_frame;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-accordion-header1, li.ui-accordion-header1, div.ui-accordion-header1
	{mso-style-name:ui-accordion-header1;
	mso-style-unhide:no;
	margin-top:1.5pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-accordion-icons1, li.ui-accordion-icons1, div.ui-accordion-icons1
	{mso-style-name:ui-accordion-icons1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-accordion-icons2, li.ui-accordion-icons2, div.ui-accordion-icons2
	{mso-style-name:ui-accordion-icons2;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-accordion-header-icon1, li.ui-accordion-header-icon1, div.ui-accordion-header-icon1
	{mso-style-name:ui-accordion-header-icon1;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-accordion-content1, li.ui-accordion-content1, div.ui-accordion-content1
	{mso-style-name:ui-accordion-content1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-button-text1, li.ui-button-text1, div.ui-button-text1
	{mso-style-name:ui-button-text1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-button-text2, li.ui-button-text2, div.ui-button-text2
	{mso-style-name:ui-button-text2;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-button-text3, li.ui-button-text3, div.ui-button-text3
	{mso-style-name:ui-button-text3;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-icon2, li.ui-icon2, div.ui-icon2
	{mso-style-name:ui-icon2;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:-6.0pt;
	text-indent:367.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-button1, li.ui-button1, div.ui-button1
	{mso-style-name:ui-button1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:-.05in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-datepicker-header1, li.ui-datepicker-header1, div.ui-datepicker-header1
	{mso-style-name:ui-datepicker-header1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-datepicker-next1, li.ui-datepicker-next1, div.ui-datepicker-next1
	{mso-style-name:ui-datepicker-next1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-datepicker-prev1, li.ui-datepicker-prev1, div.ui-datepicker-prev1
	{mso-style-name:ui-datepicker-prev1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-datepicker-title1, li.ui-datepicker-title1, div.ui-datepicker-title1
	{mso-style-name:ui-datepicker-title1;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:27.6pt;
	margin-bottom:0in;
	margin-left:27.6pt;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:21.6pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-datepicker-buttonpane1, li.ui-datepicker-buttonpane1, div.ui-datepicker-buttonpane1
	{mso-style-name:ui-datepicker-buttonpane1;
	mso-style-unhide:no;
	margin-top:8.4pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-datepicker-group1, li.ui-datepicker-group1, div.ui-datepicker-group1
	{mso-style-name:ui-datepicker-group1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-datepicker-group2, li.ui-datepicker-group2, div.ui-datepicker-group2
	{mso-style-name:ui-datepicker-group2;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-datepicker-group3, li.ui-datepicker-group3, div.ui-datepicker-group3
	{mso-style-name:ui-datepicker-group3;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-datepicker-header2, li.ui-datepicker-header2, div.ui-datepicker-header2
	{mso-style-name:ui-datepicker-header2;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-datepicker-header3, li.ui-datepicker-header3, div.ui-datepicker-header3
	{mso-style-name:ui-datepicker-header3;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-datepicker-buttonpane2, li.ui-datepicker-buttonpane2, div.ui-datepicker-buttonpane2
	{mso-style-name:ui-datepicker-buttonpane2;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-datepicker-buttonpane3, li.ui-datepicker-buttonpane3, div.ui-datepicker-buttonpane3
	{mso-style-name:ui-datepicker-buttonpane3;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-datepicker-header4, li.ui-datepicker-header4, div.ui-datepicker-header4
	{mso-style-name:ui-datepicker-header4;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-datepicker-header5, li.ui-datepicker-header5, div.ui-datepicker-header5
	{mso-style-name:ui-datepicker-header5;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-dialog-title1, li.ui-dialog-title1, div.ui-dialog-title1
	{mso-style-name:ui-dialog-title1;
	mso-style-unhide:no;
	margin-top:1.2pt;
	margin-right:12.0pt;
	margin-bottom:2.4pt;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-dialog-buttonpane1, li.ui-dialog-buttonpane1, div.ui-dialog-buttonpane1
	{mso-style-name:ui-dialog-buttonpane1;
	mso-style-unhide:no;
	margin-top:6.0pt;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:whitesmoke;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-menu-item1, li.ui-menu-item1, div.ui-menu-item1
	{mso-style-name:ui-menu-item1;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-menu-divider1, li.ui-menu-divider1, div.ui-menu-divider1
	{mso-style-name:ui-menu-divider1;
	mso-style-unhide:no;
	margin-top:3.75pt;
	margin-right:0in;
	margin-bottom:3.75pt;
	margin-left:0in;
	line-height:0%;
	mso-pagination:widow-orphan;
	font-size:1.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-state-active1, li.ui-state-active1, div.ui-state-active1
	{mso-style-name:ui-state-active1;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:-.75pt;
	margin-bottom:0in;
	margin-left:-.75pt;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#212121;}
p.ui-state-focus1, li.ui-state-focus1, div.ui-state-focus1
	{mso-style-name:ui-state-focus1;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:-.75pt;
	margin-bottom:0in;
	margin-left:-.75pt;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	background:#DADADA;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#212121;}
p.ui-menu-item2, li.ui-menu-item2, div.ui-menu-item2
	{mso-style-name:ui-menu-item2;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-icon3, li.ui-icon3, div.ui-icon3
	{mso-style-name:ui-icon3;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-indent:367.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-progressbar-value1, li.ui-progressbar-value1, div.ui-progressbar-value1
	{mso-style-name:ui-progressbar-value1;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:-.75pt;
	margin-bottom:0in;
	margin-left:-.75pt;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-progressbar-overlay1, li.ui-progressbar-overlay1, div.ui-progressbar-overlay1
	{mso-style-name:ui-progressbar-overlay1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-progressbar-value2, li.ui-progressbar-value2, div.ui-progressbar-value2
	{mso-style-name:ui-progressbar-value2;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-resizable-handle1, li.ui-resizable-handle1, div.ui-resizable-handle1
	{mso-style-name:ui-resizable-handle1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:1.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	display:none;
	mso-hide:all;}
p.ui-resizable-handle2, li.ui-resizable-handle2, div.ui-resizable-handle2
	{mso-style-name:ui-resizable-handle2;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:1.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	display:none;
	mso-hide:all;}
p.ui-menu1, li.ui-menu1, div.ui-menu1
	{mso-style-name:ui-menu1;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-selectmenu-optgroup1, li.ui-selectmenu-optgroup1, div.ui-selectmenu-optgroup1
	{mso-style-name:ui-selectmenu-optgroup1;
	mso-style-unhide:no;
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	font-weight:bold;}
p.ui-slider-handle1, li.ui-slider-handle1, div.ui-slider-handle1
	{mso-style-name:ui-slider-handle1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-slider-range1, li.ui-slider-range1, div.ui-slider-range1
	{mso-style-name:ui-slider-range1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:8.5pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-slider-handle2, li.ui-slider-handle2, div.ui-slider-handle2
	{mso-style-name:ui-slider-handle2;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:-.1in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-slider-handle3, li.ui-slider-handle3, div.ui-slider-handle3
	{mso-style-name:ui-slider-handle3;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-slider-range2, li.ui-slider-range2, div.ui-slider-range2
	{mso-style-name:ui-slider-range2;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-icon5, li.ui-icon5, div.ui-icon5
	{mso-style-name:ui-icon5;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-indent:367.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-tabs-anchor1, li.ui-tabs-anchor1, div.ui-tabs-anchor1
	{mso-style-name:ui-tabs-anchor1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-tooltip1, li.ui-tooltip1, div.ui-tooltip1
	{mso-style-name:ui-tooltip1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-widget1, li.ui-widget1, div.ui-widget1
	{mso-style-name:ui-widget1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Arial","sans-serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-state-default1, li.ui-state-default1, div.ui-state-default1
	{mso-style-name:ui-state-default1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#E6E6E6;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#555555;}
p.ui-state-default2, li.ui-state-default2, div.ui-state-default2
	{mso-style-name:ui-state-default2;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#E6E6E6;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#555555;}
p.ui-state-focus2, li.ui-state-focus2, div.ui-state-focus2
	{mso-style-name:ui-state-focus2;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#DADADA;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#212121;}
p.ui-state-hover1, li.ui-state-hover1, div.ui-state-hover1
	{mso-style-name:ui-state-hover1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#DADADA;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#212121;}
p.ui-state-focus3, li.ui-state-focus3, div.ui-state-focus3
	{mso-style-name:ui-state-focus3;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#DADADA;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#212121;}
p.ui-state-hover2, li.ui-state-hover2, div.ui-state-hover2
	{mso-style-name:ui-state-hover2;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#DADADA;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#212121;}
p.ui-state-active2, li.ui-state-active2, div.ui-state-active2
	{mso-style-name:ui-state-active2;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#212121;}
p.ui-state-active3, li.ui-state-active3, div.ui-state-active3
	{mso-style-name:ui-state-active3;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#212121;}
p.ui-state-highlight1, li.ui-state-highlight1, div.ui-state-highlight1
	{mso-style-name:ui-state-highlight1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#FBF9EE;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#363636;}
p.ui-state-highlight2, li.ui-state-highlight2, div.ui-state-highlight2
	{mso-style-name:ui-state-highlight2;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#FBF9EE;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#363636;}
p.ui-state-error1, li.ui-state-error1, div.ui-state-error1
	{mso-style-name:ui-state-error1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#FEF1EC;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#CD0A0A;}
p.ui-state-error2, li.ui-state-error2, div.ui-state-error2
	{mso-style-name:ui-state-error2;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#FEF1EC;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#CD0A0A;}
p.ui-state-error-text1, li.ui-state-error-text1, div.ui-state-error-text1
	{mso-style-name:ui-state-error-text1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#CD0A0A;}
p.ui-state-error-text2, li.ui-state-error-text2, div.ui-state-error-text2
	{mso-style-name:ui-state-error-text2;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#CD0A0A;}
p.ui-priority-primary1, li.ui-priority-primary1, div.ui-priority-primary1
	{mso-style-name:ui-priority-primary1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	font-weight:bold;}
p.ui-priority-primary2, li.ui-priority-primary2, div.ui-priority-primary2
	{mso-style-name:ui-priority-primary2;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	font-weight:bold;}
p.ui-priority-secondary1, li.ui-priority-secondary1, div.ui-priority-secondary1
	{mso-style-name:ui-priority-secondary1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-priority-secondary2, li.ui-priority-secondary2, div.ui-priority-secondary2
	{mso-style-name:ui-priority-secondary2;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-state-disabled1, li.ui-state-disabled1, div.ui-state-disabled1
	{mso-style-name:ui-state-disabled1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-state-disabled2, li.ui-state-disabled2, div.ui-state-disabled2
	{mso-style-name:ui-state-disabled2;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-icon6, li.ui-icon6, div.ui-icon6
	{mso-style-name:ui-icon6;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-indent:367.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-icon7, li.ui-icon7, div.ui-icon7
	{mso-style-name:ui-icon7;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-indent:367.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-icon8, li.ui-icon8, div.ui-icon8
	{mso-style-name:ui-icon8;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-indent:367.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-icon9, li.ui-icon9, div.ui-icon9
	{mso-style-name:ui-icon9;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-indent:367.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-icon10, li.ui-icon10, div.ui-icon10
	{mso-style-name:ui-icon10;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-indent:367.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-icon11, li.ui-icon11, div.ui-icon11
	{mso-style-name:ui-icon11;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-indent:367.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-icon12, li.ui-icon12, div.ui-icon12
	{mso-style-name:ui-icon12;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-indent:367.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-icon13, li.ui-icon13, div.ui-icon13
	{mso-style-name:ui-icon13;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-indent:367.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-icon14, li.ui-icon14, div.ui-icon14
	{mso-style-name:ui-icon14;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-indent:367.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-tabs-nav1, li.ui-tabs-nav1, div.ui-tabs-nav1
	{mso-style-name:ui-tabs-nav1;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.tertiary1, li.tertiary1, div.tertiary1
	{mso-style-name:tertiary1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#666666;}
p.tertiary2, li.tertiary2, div.tertiary2
	{mso-style-name:tertiary2;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#985735;}
p.ui-tabs-panel1, li.ui-tabs-panel1, div.ui-tabs-panel1
	{mso-style-name:ui-tabs-panel1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-tabs-hide1, li.ui-tabs-hide1, div.ui-tabs-hide1
	{mso-style-name:ui-tabs-hide1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	display:none;
	mso-hide:all;}
p.ui-dialog-titlebar1, li.ui-dialog-titlebar1, div.ui-dialog-titlebar1
	{mso-style-name:ui-dialog-titlebar1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#3E72A6;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:white;}
p.ui-dialog-titlebar-close1, li.ui-dialog-titlebar-close1, div.ui-dialog-titlebar-close1
	{mso-style-name:ui-dialog-titlebar-close1;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-dialog-content1, li.ui-dialog-content1, div.ui-dialog-content1
	{mso-style-name:ui-dialog-content1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-resizable-se1, li.ui-resizable-se1, div.ui-resizable-se1
	{mso-style-name:ui-resizable-se1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-icon15, li.ui-icon15, div.ui-icon15
	{mso-style-name:ui-icon15;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-indent:367.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-state-hover3, li.ui-state-hover3, div.ui-state-hover3
	{mso-style-name:ui-state-hover3;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#DADADA;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#212121;}
p.ui-ncbibutton-submit1, li.ui-ncbibutton-submit1, div.ui-ncbibutton-submit1
	{mso-style-name:ui-ncbibutton-submit1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:6.55pt;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbibutton-cancel1, li.ui-ncbibutton-cancel1, div.ui-ncbibutton-cancel1
	{mso-style-name:ui-ncbibutton-cancel1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	line-height:22.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#2F4A8B;}
p.ui-button-text4, li.ui-button-text4, div.ui-button-text4
	{mso-style-name:ui-button-text4;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbiautocomplete-link-pref-right1, li.ui-ncbiautocomplete-link-pref-right1, div.ui-ncbiautocomplete-link-pref-right1
	{mso-style-name:ui-ncbiautocomplete-link-pref-right1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:right;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-button-text5, li.ui-button-text5, div.ui-button-text5
	{mso-style-name:ui-button-text5;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-button-text6, li.ui-button-text6, div.ui-button-text6
	{mso-style-name:ui-button-text6;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-button-text7, li.ui-button-text7, div.ui-button-text7
	{mso-style-name:ui-button-text7;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-indent:595.95pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-button-text8, li.ui-button-text8, div.ui-button-text8
	{mso-style-name:ui-button-text8;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-indent:595.95pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-button-text9, li.ui-button-text9, div.ui-button-text9
	{mso-style-name:ui-button-text9;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-button-text10, li.ui-button-text10, div.ui-button-text10
	{mso-style-name:ui-button-text10;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-icon16, li.ui-icon16, div.ui-icon16
	{mso-style-name:ui-icon16;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-indent:367.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-icon17, li.ui-icon17, div.ui-icon17
	{mso-style-name:ui-icon17;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-indent:367.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-icon18, li.ui-icon18, div.ui-icon18
	{mso-style-name:ui-icon18;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-indent:367.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-icon19, li.ui-icon19, div.ui-icon19
	{mso-style-name:ui-icon19;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-indent:367.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-icon20, li.ui-icon20, div.ui-icon20
	{mso-style-name:ui-icon20;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-indent:367.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-icon21, li.ui-icon21, div.ui-icon21
	{mso-style-name:ui-icon21;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-indent:367.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-button-icon-primary1, li.ui-button-icon-primary1, div.ui-button-icon-primary1
	{mso-style-name:ui-button-icon-primary1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-button-icon-primary2, li.ui-button-icon-primary2, div.ui-button-icon-primary2
	{mso-style-name:ui-button-icon-primary2;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-button-icon-primary3, li.ui-button-icon-primary3, div.ui-button-icon-primary3
	{mso-style-name:ui-button-icon-primary3;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-button-icon-secondary1, li.ui-button-icon-secondary1, div.ui-button-icon-secondary1
	{mso-style-name:ui-button-icon-secondary1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-button-icon-secondary2, li.ui-button-icon-secondary2, div.ui-button-icon-secondary2
	{mso-style-name:ui-button-icon-secondary2;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbigrid-paged-pagecontrol1, li.ui-ncbigrid-paged-pagecontrol1, div.ui-ncbigrid-paged-pagecontrol1
	{mso-style-name:ui-ncbigrid-paged-pagecontrol1;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:right;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.prev1, li.prev1, div.prev1
	{mso-style-name:prev1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:.1in;
	mso-margin-bottom-alt:auto;
	margin-left:2.4pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.next1, li.next1, div.next1
	{mso-style-name:next1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:2.4pt;
	mso-margin-bottom-alt:auto;
	margin-left:.1in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbigrid-select-row-count1, li.ui-ncbigrid-select-row-count1, div.ui-ncbigrid-select-row-count1
	{mso-style-name:ui-ncbigrid-select-row-count1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	font-weight:bold;}
p.ui-ncbigrid-outer-div1, li.ui-ncbigrid-outer-div1, div.ui-ncbigrid-outer-div1
	{mso-style-name:ui-ncbigrid-outer-div1;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbimenu-item-leaf1, li.ui-ncbimenu-item-leaf1, div.ui-ncbimenu-item-leaf1
	{mso-style-name:ui-ncbimenu-item-leaf1;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:9.0pt;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.brieflinkpop1, li.brieflinkpop1, div.brieflinkpop1
	{mso-style-name:brieflinkpop1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.star1, li.star1, div.star1
	{mso-style-name:star1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:7.4pt;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.jig-ncbisetswitch1, li.jig-ncbisetswitch1, div.jig-ncbisetswitch1
	{mso-style-name:jig-ncbisetswitch1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	line-height:14.75pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#333333;}
p.ui-ncbisetswitch-button1, li.ui-ncbisetswitch-button1, div.ui-ncbisetswitch-button1
	{mso-style-name:ui-ncbisetswitch-button1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-icon24, li.ui-icon24, div.ui-icon24
	{mso-style-name:ui-icon24;
	mso-style-unhide:no;
	margin:5.55pt;
	text-indent:367.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ltd-hover1, li.ltd-hover1, div.ltd-hover1
	{mso-style-name:ltd-hover1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#E8E8E8;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-icon25, li.ui-icon25, div.ui-icon25
	{mso-style-name:ui-icon25;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-indent:367.15pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.ui-ncbisetswitch-options1, li.ui-ncbisetswitch-options1, div.ui-ncbisetswitch-options1
	{mso-style-name:ui-ncbisetswitch-options1;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.pbody1, li.pbody1, div.pbody1
	{mso-style-name:pbody1;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:16.6pt;
	margin-bottom:0in;
	margin-left:16.6pt;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.page-box1, li.page-box1, div.page-box1
	{mso-style-name:page-box1;
	mso-style-unhide:no;
	margin-top:16.6pt;
	margin-right:0in;
	margin-bottom:16.6pt;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#F8F8F8;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.page-box-wide1, li.page-box-wide1, div.page-box-wide1
	{mso-style-name:page-box-wide1;
	mso-style-unhide:no;
	margin-top:16.6pt;
	margin-right:0in;
	margin-bottom:16.6pt;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#F8F8F8;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.nomaxwidth1, li.nomaxwidth1, div.nomaxwidth1
	{mso-style-name:no_max_width1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.content1, li.content1, div.content1
	{mso-style-name:content1;
	mso-style-unhide:no;
	margin:16.6pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.boxed-text-box1, li.boxed-text-box1, div.boxed-text-box1
	{mso-style-name:boxed-text-box1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.f1, li.f1, div.f1
	{mso-style-name:f1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.l1, li.l1, div.l1
	{mso-style-name:l1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.cell-from1, li.cell-from1, div.cell-from1
	{mso-style-name:cell-from1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	font-weight:bold;}
p.cell-citation1, li.cell-citation1, div.cell-citation1
	{mso-style-name:cell-citation1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.figpopup1, li.figpopup1, div.figpopup1
	{mso-style-name:figpopup1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.button1, li.button1, div.button1
	{mso-style-name:button1;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	mso-pagination:widow-orphan;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#336699;}
p.retraction1, li.retraction1, div.retraction1
	{mso-style-name:retraction1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:red;
	font-size:12.0pt;
	font-family:"Helvetica","sans-serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#F0F0F0;}
p.warn1, li.warn1, div.warn1
	{mso-style-name:warn1;
	mso-style-unhide:no;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.notice1, li.notice1, div.notice1
	{mso-style-name:notice1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:16.5pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.arrowtab1, li.arrowtab1, div.arrowtab1
	{mso-style-name:arrowtab1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	background:#F8F8F8;
	font-size:12.0pt;
	font-family:"Arial","sans-serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.thistab1, li.thistab1, div.thistab1
	{mso-style-name:thistab1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	background:#F6F6F6;
	font-size:9.5pt;
	font-family:"Arial","sans-serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	font-weight:bold;}
p.onelinesource1, li.onelinesource1, div.onelinesource1
	{mso-style-name:one_line_source1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	background:#E0E0E0;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.mathjaxhoverarrow1, li.mathjaxhoverarrow1, div.mathjaxhoverarrow1
	{mso-style-name:mathjax_hover_arrow1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:7.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	color:#F0F0F0;}
p.mathjaxmenuarrow1, li.mathjaxmenuarrow1, div.mathjaxmenuarrow1
	{mso-style-name:mathjax_menuarrow1;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:"Arial Unicode MS","sans-serif";
	color:white;}
p.p, li.p, div.p
	{mso-style-name:p;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
p.msochpdefault, li.msochpdefault, div.msochpdefault
	{mso-style-name:msochpdefault;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Calibri","sans-serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	mso-bidi-font-family:"Times New Roman";}
p.msopapdefault, li.msopapdefault, div.msopapdefault
	{mso-style-name:msopapdefault;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	margin-bottom:10.0pt;
	margin-left:0in;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;}
span.other-issues
	{mso-style-name:other-issues;
	mso-style-unhide:no;}
span.underline
	{mso-style-name:underline;
	mso-style-unhide:no;}
span.double-underline
	{mso-style-name:double-underline;
	mso-style-unhide:no;}
span.bold-double-underline
	{mso-style-name:bold-double-underline;
	mso-style-unhide:no;}
span.ui-icon1
	{mso-style-name:ui-icon1;
	mso-style-unhide:no;
	display:none;
	mso-hide:all;}
span.ui-selectmenu-text
	{mso-style-name:ui-selectmenu-text;
	mso-style-unhide:no;}
span.pagelink
	{mso-style-name:page_link;
	mso-style-unhide:no;}
span.ui-icon-plus-minus-big
	{mso-style-name:ui-icon-plus-minus-big;
	mso-style-unhide:no;}
span.ui-icon-plus-minus-big-open
	{mso-style-name:ui-icon-plus-minus-big-open;
	mso-style-unhide:no;}
span.collapsabletbodyicon
	{mso-style-name:collapsabletbodyicon;
	mso-style-unhide:no;}
span.ui-icon4
	{mso-style-name:ui-icon4;
	mso-style-unhide:no;
	display:none;
	mso-hide:all;}
span.ui-selectmenu-text1
	{mso-style-name:ui-selectmenu-text1;
	mso-style-unhide:no;
	display:none;
	mso-hide:all;}
span.pagelink1
	{mso-style-name:page_link1;
	mso-style-unhide:no;
	color:#CCCCCC;}
span.collapsabletbodyicon1
	{mso-style-name:collapsabletbodyicon1;
	mso-style-unhide:no;}
span.ui-icon-plus-minus-big1
	{mso-style-name:ui-icon-plus-minus-big1;
	mso-style-unhide:no;}
span.ui-icon-plus-minus-big-open1
	{mso-style-name:ui-icon-plus-minus-big-open1;
	mso-style-unhide:no;}
span.ui-icon-plus-minus-big2
	{mso-style-name:ui-icon-plus-minus-big2;
	mso-style-unhide:no;}
span.ui-icon-plus-minus-big-open2
	{mso-style-name:ui-icon-plus-minus-big-open2;
	mso-style-unhide:no;}
span.ui-icon22
	{mso-style-name:ui-icon22;
	mso-style-unhide:no;
	display:none;
	mso-hide:all;}
span.ui-icon23
	{mso-style-name:ui-icon23;
	mso-style-unhide:no;
	display:none;
	mso-hide:all;}
span.cit
	{mso-style-name:cit;
	mso-style-unhide:no;}
span.fm-vol-iss-date
	{mso-style-name:fm-vol-iss-date;
	mso-style-unhide:no;}
span.doi1
	{mso-style-name:doi1;
	mso-style-unhide:no;}
span.fm-citation-ids-label
	{mso-style-name:fm-citation-ids-label;
	mso-style-unhide:no;}
span.contrib-email
	{mso-style-name:contrib-email;
	mso-style-unhide:no;}
span.tag-json
	{mso-style-name:tag-json;
	mso-style-unhide:no;}
span.figpopup-sensitive-area1
	{mso-style-name:figpopup-sensitive-area1;
	mso-style-unhide:no;
	mso-text-animation:none;
	text-decoration:none;
	text-underline:none;
	text-decoration:none;
	text-line-through:none;}
span.citation
	{mso-style-name:citation;
	mso-style-unhide:no;}
span.ref-journal
	{mso-style-name:ref-journal;
	mso-style-unhide:no;}
span.ref-vol
	{mso-style-name:ref-vol;
	mso-style-unhide:no;}
span.nowrap
	{mso-style-name:nowrap;
	mso-style-unhide:no;}
span.SpellE
	{mso-style-name:"";
	mso-spl-e:yes;}
span.GramE
	{mso-style-name:"";
	mso-gram-e:yes;}
.MsoChpDefault
	{mso-style-type:export-only;
	mso-default-props:yes;
	font-size:10.0pt;
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Calibri","sans-serif";
	mso-ascii-font-family:Calibri;
	mso-hansi-font-family:Calibri;}
.MsoPapDefault
	{mso-style-type:export-only;
	margin-bottom:10.0pt;
	line-height:115%;}
@page WordSection1
	{size:8.5in 11.0in;
	margin:1.0in 1.0in 1.0in 1.0in;
	mso-header-margin:.5in;
	mso-footer-margin:.5in;
	mso-paper-source:0;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 @list l0
	{mso-list-id:450629666;
	mso-list-template-ids:1137226156;}
ol
	{margin-bottom:0in;}
ul
	{margin-bottom:0in;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin-top:0in;
	mso-para-margin-right:0in;
	mso-para-margin-bottom:10.0pt;
	mso-para-margin-left:0in;
	line-height:115%;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Calibri","sans-serif";}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="1026"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=EN-US link=blue vlink=purple style='tab-interval:.5in'>

<div class=WordSection1>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-no-proof:yes'><img width=480 height=75
id="_x0000_i1039" src="PMC2474852%20table%202_files/image001.png"></span><span
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-no-proof:
yes'><img width=480 height=75 id="_x0000_i1038"
src="PMC2474852%20table%202_files/image002.png" alt="Logo of bmccanc"></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span class=GramE><span lang=EN style='font-size:12.0pt;font-family:
"Times New Roman","serif";mso-ansi-language:EN'>BMC Cancer.</span></span><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'> <span class=GramE>2008; 8: 189.</span> </span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>Published online 2008 Jul 2. <span class=SpellE><span
class=GramE>doi</span></span>:&nbsp; </span><a
href="http://dx.doi.org/10.1186%2F1471-2407-8-189" target="pmc_ext"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>10.1186/1471-2407-8-189</span></a></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>PMCID: PMC2474852</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:24.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>TDAG51 is an ERK signaling target that opposes ERK-mediated HME16C mammary
epithelial cell transformation</span></b></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Oberst%20MD%5Bauth%5D"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>Michael D Oberst</span></a><span class=GramE><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>,<sup>1</sup></span></span><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'> </span><a
href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Beberman%20SJ%5Bauth%5D"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>Stacey J Beberman</span></a><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>,<sup>1</sup> </span><a
href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Zhao%20L%5Bauth%5D"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>Liu Zhao</span></a><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN'>,<sup>1</sup> </span><a
href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Yin%20JJ%5Bauth%5D"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>Juan <span class=SpellE>Juan</span> Yin</span></a><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>,<sup>1</sup> </span><a
href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ward%20Y%5Bauth%5D"><span
class=SpellE><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>Yvona</span></span><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN'> Ward</span></a><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>,<sup>1</sup> and </span><a
href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Kelly%20K%5Bauth%5D"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>Kathleen Kelly</span></a><sup><span style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-no-proof:yes'><img border=0
width=7 height=9 id="_x0000_i1037"
src="PMC2474852%20table%202_files/image003.gif" alt="corresponding author"></span></sup><sup><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>1</span></sup></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><sup><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
display:none;mso-hide:all;mso-ansi-language:EN'>1</span></sup><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";display:none;
mso-hide:all;mso-ansi-language:EN'>Cell and Cancer Biology Branch, Center for
Cancer Research, National Cancer Institute, National Institutes of Health, 37
Convent Drive, Room 1066, Bethesda, MD 20892, USA</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><sup><span style='font-size:12.0pt;font-family:"Times New Roman","serif";
display:none;mso-hide:all;mso-no-proof:yes'><img border=0 width=7 height=9
id="_x0000_i1036" src="PMC2474852%20table%202_files/image003.gif"
alt="corresponding author"></span></sup><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";display:none;mso-hide:all;mso-ansi-language:
EN'>Corresponding author.</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
display:none;mso-hide:all;mso-ansi-language:EN'>Michael D Oberst: </span><a
href="mailto:dev@null"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
display:none;mso-hide:all;mso-ansi-language:EN'>moc.liamg@tsreboleahcim</span></a><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
display:none;mso-hide:all;mso-ansi-language:EN'>; Stacey J Beberman: </span><a
href="mailto:dev@null"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
display:none;mso-hide:all;mso-ansi-language:EN'>moc.liamg@511bjs</span></a><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
display:none;mso-hide:all;mso-ansi-language:EN'>; Liu Zhao: </span><a
href="mailto:dev@null"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
display:none;mso-hide:all;mso-ansi-language:EN'>moc.liamg@ymmijlac</span></a><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
display:none;mso-hide:all;mso-ansi-language:EN'>; Juan Juan Yin: </span><a
href="mailto:dev@null"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
display:none;mso-hide:all;mso-ansi-language:EN'>vog.hin.liam@naujniy</span></a><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
display:none;mso-hide:all;mso-ansi-language:EN'>; Yvona Ward: </span><a
href="mailto:dev@null"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
display:none;mso-hide:all;mso-ansi-language:EN'>vog.hin.xileh@drawy</span></a><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
display:none;mso-hide:all;mso-ansi-language:EN'>; Kathleen Kelly: </span><a
href="mailto:dev@null"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
display:none;mso-hide:all;mso-ansi-language:EN'>vog.hin.liam@akyllek</span></a><span
style='font-size:12.0pt;font-family:"Times New Roman","serif";display:none;
mso-hide:all;mso-ansi-language:EN'> </span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>Author information &#9658;</span></a><span
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'> </span><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>Article notes &#9658;</span></a><span style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'> </span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Copyright and License information &#9658;</span></a></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
display:none;mso-hide:all;mso-ansi-language:EN'>Received 2008 Jan 24; Accepted
2008 Jul 2.</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/about/copyright.html"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
display:none;mso-hide:all;mso-ansi-language:EN'>Copyright</span></a><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
display:none;mso-hide:all;mso-ansi-language:EN'> � 2008 Oberst et al; licensee
BioMed Central Ltd.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";display:none;mso-hide:all;
mso-ansi-language:EN'>This is an Open Access article distributed under the
terms of the Creative Commons Attribution License (</span><a
href="http://creativecommons.org/licenses/by/2.0" target="pmc_ext"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
display:none;mso-hide:all;mso-ansi-language:EN'>http://creativecommons.org/licenses/by/2.0</span></a><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
display:none;mso-hide:all;mso-ansi-language:EN'>), which permits unrestricted
use, distribution, and reproduction in any medium, provided the original work
is properly cited.</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>This article has been </span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/citedby/"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>cited by</span></a><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN'> other articles in
PMC.</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/"
title="Go to other sections in this page"><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN'>Go to:</span></a></p>

<div style='border:none;border-bottom:solid #97B0C8 1.0pt;padding:0in 0in 0in 0in'>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:18.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Abstract</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Introduction</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>Signaling
downstream of <span class=SpellE>Ras</span> is mediated by three major
pathways, <span class=SpellE>Raf</span>/ERK, phosphatidylinositol 3 kinase
(PI3K), and <span class=SpellE>Ral</span> guanine nucleotide exchange factor (<span
class=SpellE>RalGEF</span>). <span class=SpellE>Ras</span> signal transduction
pathways play an important role in breast cancer progression, as evidenced by
the frequent over-expression of the <span class=SpellE>Ras</span>-activating
epidermal growth factor receptors EGFR and ErbB2. <span style='background:yellow;
mso-highlight:yellow'>Here we investigated which signal transduction pathways
downstream of <span class=SpellE>Ras</span> contribute to EGFR-dependent
transformation of telomerase-immortalized mammary epithelial cells HME16C.</span>
<span style='background:yellow;mso-highlight:yellow'>Furthermore, we examined
whether a highly transcriptionally regulated ERK pathway target, PHLDA1
(TDAG51), suggested to be a tumor suppressor in breast cancer and melanoma,
might modulate the transformation process.</span></span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Methods</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>Cellular
transformation of human mammary epithelial cells by downstream <span
class=SpellE>Ras</span> signal transduction pathways was examined using anchorage-independent
growth assays in the presence and absence of EGFR inhibition. TDAG51 protein
expression was down-regulated by interfering small hairpin RNA (shRNA), and the
effects on cell proliferation and death were examined in <span class=SpellE>Ras</span>
pathway-transformed breast epithelial cells.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Results</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>Activation
of both the ERK and PI3K signaling pathways was sufficient to induce cellular
transformation, which was accompanied by up-regulation of EGFR ligands,
suggesting autocrine EGFR stimulation during the transformation process. Only
activation of the ERK pathway was sufficient to transform cells in the presence
of EGFR inhibition and was sufficient for tumorigenesis in xenografts. <span
style='background:yellow;mso-highlight:yellow'>Up-regulation of the PHLDA1 gene
product, TDAG51, was found to correlate with persistent ERK activation and
anchorage-independent growth in the absence or presence of EGFR inhibition.</span>
Knockdown of this putative breast <span class=GramE>cancer</span>
tumor-suppressor gene resulted in increased ERK pathway activation and enhanced
matrix-detached cellular proliferation of <span class=SpellE>Ras</span>/<span
class=SpellE>Raf</span> transformed cells.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Conclusion</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>Our results
suggest that multiple <span class=SpellE>Ras</span> signal transduction
pathways contribute to mammary epithelial cell transformation, but that the ERK
signaling pathway may be a crucial component downstream of EGFR activation
during tumorigenesis. Furthermore, persistent activation of ERK signaling
up-regulates TDAG51. <span style='background:yellow;mso-highlight:yellow'>This
event serves as a negative regulator of both <span class=SpellE>Erk</span>
activation as well as matrix-detached cellular proliferation and suggests that
TDAG51 opposes ERK-mediated transformation in breast epithelial cells.</span></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/"
title="Go to other sections in this page"><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN'>Go to:</span></a></p>

<div style='border:none;border-bottom:solid #97B0C8 1.0pt;padding:0in 0in 0in 0in'>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:18.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Background</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>The
development and progression of breast cancer is the result of multiple genetic
changes, which lead to complex alterations in signal transduction networks in
breast cancer cells relative to their normal epithelial counterparts. Signaling
differences between tumor and normal cells are reflected in altered gene
expression patterns, a finding that has been widely investigated using various
molecular techniques. Patterns of differential gene expression have been used
for classification and prognostication of certain cancers and may be valuable
for prospectively predicting responsiveness to therapeutic treatments [</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B1"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>1</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>]. <span class=GramE>In addition to serving as
biomarkers, some differentially expressed gene products have been informative
in defining the physiological differences between normal and cancer cells.</span>
In order to understand the impact of dysregulated signaling pathways upon gene
expression and function, it is necessary to connect differential gene
expression to upstream signaling pathways.</span></p>

<p class=MsoNormal style='line-height:normal'><span class=SpellE><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Ras</span></span><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'> activation is a common intermediary in signaling
pathways initiated by a variety of cell surface receptors, and signaling
pathways downstream of <span class=SpellE>Ras</span> have been implicated
repeatedly in oncogenesis. <span class=SpellE>Ras</span> proteins are
frequently mutated to an activated form in human cancers, particularly in tumors
of the pancreas, colon, thyroid, and lung [</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B2"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>2</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>]. <span class=SpellE>Ras</span> mutations are rare in
breast cancer, where the mutation rate is less than 5% [</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B3"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>3</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>]. However, <span class=SpellE>Ras</span> signaling is
hyperactive in many primary breast tumors [</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B4"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>4</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>]. This is most likely due to the activation of growth
factor receptors that activate <span class=SpellE>Ras</span> exchange factors,
such as the epidermal growth factor receptors EGFR (ErbB1) and ErbB2 (HER2/<span
class=SpellE>neu</span>) and the colony stimulating factor-1 (CSF-1) receptor
c-<span class=SpellE>fms</span> [</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B5"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>5</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>,</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B6"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>6</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>]. EGFR and ErbB2 receptor over-expression occurs in one
quarter to one-half of all breast tumors, and this correlates with a significantly
decreased disease-free and overall survival rates [</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B5"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>5</span></a><span class=GramE><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN'>,</span></span><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B7">7</a>]. In
addition, ligands for the EGFR such as transforming growth factor-a, <span
class=SpellE>amphiregulin</span>, <span class=SpellE>epiregulin</span>, <span
class=SpellE>betacellulin</span>, and heparin-binding EGF stimulate the
receptor in primary breast tumors to enhance local growth and progression of
the disease [</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B8"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>8</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>]. Finally, activating mutations in the PI3K pathway, an
immediate downstream effector of <span class=SpellE>Ras</span>, occur in a
subset of breast tumors [</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B9"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>9</span></a><span class=GramE><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN'>,</span></span><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B10">10</a>]. Taken
together, these findings suggest that breast cancer is a relevant model in
which to study the biology of downstream <span class=SpellE>Ras</span> signal
transduction.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>The <span
class=SpellE>Ras</span> oncogene binds numerous effectors that in turn activate
a variety of signaling pathways. The most highly characterized of these are the
<span class=SpellE><span class=GramE>Raf</span></span> proteins, PI3K, and the <span
class=SpellE>Ral</span> guanidine nucleotide exchange factors (<span
class=SpellE>RalGEFs</span>), although <span class=SpellE>Ras</span> does
recruit and activate other potentially transforming effectors [</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B11"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>11</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>]. The dissection of individual <span class=SpellE>Ras</span>
signaling pathways is possible using effector domain mutants (EDMs) of <span
class=SpellE>Ras</span>, for which single amino acid mutations in the effector
binding domain allow the binding and activation of specific effectors, but not
others [</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B12"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>12</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>]. These <span class=SpellE>Ras</span> EDMs, together
with activated or dominant-negative versions of downstream effectors, have been
used to characterize the pathways that contribute to the transformation of
immortalized cells.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>In mammary
epithelial cells, both species- as well as cell line-dependent differences in <span
class=SpellE>Ras</span> downstream signaling pathways have been found to induce
tumorigenesis and/or anchorage-independent growth, a measure of <i>in vitro </i>transformation.
Studies using immortalized <i>mouse </i>EpH4 mammary epithelial cells have
implicated <span class=SpellE><span class=GramE>Raf</span></span> as well as
PI3K pathways in supporting transformation and tumorigenesis [</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B13"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>13</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>]. For <i>human </i>immortalized mammary epithelial
cells, <span class=SpellE>Raf</span> and PI3K clearly contribute to transformation,
although each is usually not sufficient for tumor formation in animal models [</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B14"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>14</span></a><span class=GramE><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN'>,</span></span><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B15">15</a>]. In
fact, the immortalized human breast epithelial cell line HMLE required
simultaneous activation of <span class=SpellE><span class=GramE>Raf</span></span>,
PI3K, and the <span class=SpellE>RalGEF</span> pathways for maximal
anchorage-independent growth and tumorigenic transformation [</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B14"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>14</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>].</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>Dissecting
the physiological consequences of individual <span class=SpellE>Ras</span>-mediated
signaling pathways with respect to mammary epithelial transformation is of
obvious interest. The ability of activated <span class=SpellE>Ras</span> and <span
class=SpellE><span class=GramE>Raf</span></span> to induce autocrine expression
of epidermal-like growth factors has been implicated in the protection of
MCF10A mammary epithelial cells from <span class=SpellE>anoikis</span> [</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B16"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>16</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>]. Using HMEC16C cells, a telomerase-immortalized human
mammary epithelial cell line, we have investigated the contribution of EGFR
signaling to anchorage-independent growth initiated by <span class=SpellE><span
class=GramE>Raf</span></span> and additional signaling pathways downstream of <span
class=SpellE>Ras</span>. We determined that ERK but not PI3K or <span
class=SpellE>RalGEF</span> activation of HMEC16C cells supports anchorage
independent proliferation independent of EGFR activation.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>We performed
a functional analysis of one gene in particular, TDAG51, whose expression is
regulated by ERK through EGFR dependent and independent mechanisms. The loss of
TDAG51 mRNA and protein has been correlated with breast adenocarcinoma and
melanoma progression in clinical samples [</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B17"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>17</span></a><span class=GramE><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN'>,</span></span><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B18">18</a>]. The
importance of TDAG51 regulation on the transformed phenotype of <span
class=SpellE>Ras</span>-infected cells was addressed using TDAG51-specific
interfering small hairpin RNA (shRNA) to reduce TDAG51 levels. Consistent with
a tumor suppressor role, loss of TDAG51 increased ERK-mediated cellular
proliferation.</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/"
title="Go to other sections in this page"><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN'>Go to:</span></a></p>

<div style='border:none;border-bottom:solid #97B0C8 1.0pt;padding:0in 0in 0in 0in'>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:18.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Methods</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Culture of human epithelial cell lines</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>HME16C human
mammary cells [</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B19"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>19</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>] were cultured in <span class=SpellE>Clonetics</span>
Mammary Epithelial Basal Media (MEBM) with MEGM <span class=SpellE>SingleQuot</span>
supplements (<span class=SpellE>Cambrex</span>), and HEK-HT human embryonic
kidney epithelial cells [</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B20"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>20</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>] in DMEM (Invitrogen) plus 10% fetal bovine serum
(Invitrogen). All cells were maintained at 37�C and 5% CO<sub>2</sub>. For
induction of proteins from the tetracycline-inducible retroviral expression
vector <span class=SpellE>pLRT</span>, 250 ng/mL of doxycycline (Sigma-Aldrich)
was added to culture media.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Retroviral and lentiviral constructs and infections</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>Constructs
for the inducible expression of H-<span class=SpellE>Ras</span>, H-<span
class=SpellE>Ras</span> effector domain mutants, and <span class=SpellE>Rlf</span>-CAAX
were created by PCR <span class=SpellE>subcloning</span> the sequences of
HA-tagged H-RasG12V (Ras<sup>V12</sup>), H-RasG12V, E37G (Ras<sup>V12G37</sup>),
H-RasG12V, T35S (Ras<sup>V12S35</sup>), H-RasG12V, Y40C (Ras<sup>V12C40</sup>),
and <span class=SpellE>Rlf</span>-CAAX [</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B21"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>21</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>] into the tetracycline-inducible retroviral expression
vector <span class=SpellE>pLRT</span> [</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B22"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>22</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>]. The generation of retroviruses and lentiviruses was as
described [</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B23"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>23</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>]. Polyclonal populations of <span class=SpellE>pLRT</span>
infected cells were selected with 5 <span class=SpellE>&#956;g</span>/mL <span
class=SpellE>blasticidin</span>. The expression of the anti-TDAG51 shRNA 36-1
was accomplished by sub-cloning the anti-TDAG51 shRNA sequence
5'-GGAACTGCACTTCTCCAACTTCAAGAGAGTTGGAGAAGTGCAGTTCCTTTTT-3' into the <span
class=SpellE>pLVTHM</span> lentivirus (kindly provided by Dr. D. <span
class=SpellE>Trono</span>, Lausanne, Switzerland; [</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B24"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>24</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>]). After infection, cells with integrated lentivirus
were selected by sterile sorting for GFP. Three sterile sorts were performed to
acquire a polyclonal population of cells exclusively expressing GFP that was
subsequently examined for TDAG51 protein reduction by western blotting.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Western blotting and <span class=SpellE>Ral</span> activation assays</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>Western
blots were performed using <span class=SpellE>Chemilluminescence</span>
(Pierce). Antibodies used for western blots included anti-<span class=SpellE>Ras</span>
<span class=SpellE>mAb</span> (BD Biosciences, cat#</span><a
href="http://www.ncbi.nlm.nih.gov/nuccore/R02120"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";display:none;
mso-hide:all;mso-ansi-language:EN'>{&quot;type&quot;:&quot;entrez-nucleotide&quot;,&quot;attrs&quot;:{&quot;text&quot;:&quot;R02120&quot;,&quot;term_id&quot;:&quot;751856&quot;,&quot;term_text&quot;:&quot;R02120&quot;}}</span><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>R02120</span></a><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN'>), rat anti-HA <span
class=SpellE>mAb</span> (Roche, cat#1988506), anti-<span class=SpellE>phospho</span>
<span class=SpellE>Erk</span> <span class=SpellE>mAb</span> (Santa Cruz,
cat#sc-7383), goat anti- Erk2 (Santa Cruz, C14-G, cat#154-G), rabbit anti-<span
class=SpellE>phospho</span>-<span class=SpellE>Akt</span> Ser473 (Cell
Signaling Technology), goat anti-<span class=SpellE>Akt</span> (Santa Cruz,
C-20, cat#sc-1618), or an anti-alpha tubulin <span class=SpellE>mAb</span>
(clone DM1A, <span class=SpellE>NeoMarkers</span>), followed by detection using
appropriate anti-mouse, rabbit, or goat HRP-conjugated secondary antibodies
(Jackson Labs) and ECL detection. For <span class=SpellE>Ral</span> activation
assays, the <span class=SpellE>Ral</span> Activation Assay Kit (Upstate Cell
Signaling Solutions) was used according to the manufacturer's protocol.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Soft agar assays</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>Cells were <span
class=SpellE>trypsinized</span>, neutralized, and 1.2 � 10<sup>4 </sup>cells
were plated per well in 0.36% <span class=SpellE>bacto</span>-agar (BD
Biosciences), w/v in growth media, on a 0.6% <span class=SpellE>bacto</span>-agar
support in 6-well culture plates. Prior to cell plating, 250 ng/mL doxycycline,
DMSO vehicle, or the anti-EGFR compound PD153035 (<span class=SpellE>Calbiochem</span>),
was added to the agar, as appropriate. Appropriately-<span class=SpellE>supplememented</span>
fresh media was added to wells every 4 days. Colonies greater than 100 <span
class=SpellE>&#956;m</span> in diameter were counted after 18 days using a 2�
lens equipped with a graded grid to determine colony size.</span></p>

<p class=MsoNormal style='line-height:normal'><span class=SpellE><b><span
lang=EN style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>Alamar</span></b></span><b><span lang=EN
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'> Blue growth assays in ultra-low attachment tissue culture plates</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>Cells were <span
class=SpellE>trypsinized</span> and plated in 500 <span class=SpellE>&#956;L</span>
appropriate growth media into 24-well ultra-low attachment plates (Corning) at
25,000 cells per well. At the times <span class=GramE>indicated,</span> 50 <span
class=SpellE>&#956;L</span> of <span class=SpellE>alamar</span> blue (BioSource
International) was added to each well and incubated for 6 hours under standard
culture conditions. The amount of <span class=SpellE>alamar</span> blue
reduction was quantified by measuring the fluorescence of each sample at 530 nm
excitation/590 nm emission, corrected for the background fluorescence in wells
containing media but no cells. The number of cells for initial plating and the <span
class=SpellE>alamar</span> blue incubation times were determined by generating
a standard curve of fluorescence versus cell number incubated with <span
class=SpellE>alamar</span> blue for various times. Plating cells initially at
25,000/well insures that fluorescence measurements will occur on a linear part
of the curve with a 6-hour incubation time over the course of an experiment. It
was determined that TDAG51-specific shRNA did not affect the redox potential of
HME16C at various cell numbers. Statistical analysis was performed using 2-way
analysis of variance (ANOVA) with Bonferroni post-tests using the <span
class=SpellE>GraphPad</span> Prism software program (<span class=SpellE>GraphPad</span>
Software, Inc.).</span></p>

<p class=MsoNormal style='line-height:normal'><span class=SpellE><b><span
lang=EN style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>Tumorigenicity</span></b></span><b><span lang=EN
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'> assays</span></b></p>

<p class=MsoNormal style='line-height:normal'><span class=SpellE><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Tumorigenicity</span></span><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN'> assays were done
essentially as described [</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B23"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>23</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>]. To induce gene expression, cells were treated with 250
ng/mL doxycycline three days prior to injection, and mice were fed with
doxycycline-containing diet (200 mg/kg, <span class=SpellE>BioServ</span>,
Inc.) beginning four days prior to cell inoculation and continuing for the
duration of the experiment.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Microarray analysis</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>Total RNA
was extracted using <span class=SpellE>Trizol</span> reagent (Invitrogen) after
treatment of cells with 250 ng/mL doxycycline for 72 hours to induce gene expression,
or with doxycycline and <span class=GramE>0.25 <span class=SpellE>&#956;M</span>
EGFR receptor kinase inhibitor PD153035 as indicated</span>. Twenty micrograms
of RNA were used for cDNA generation, and cDNA labeled with Cy3 or Cy5 <span
class=SpellE>monofunctional</span> reactive dye to amino allyl-modified <span
class=SpellE>dUTP</span> incorporated into cDNA using the <span class=SpellE>FairPlay</span>
Microarray labeling kit (<span class=SpellE>Stratagene</span>). Labeled cDNA
was hybridized to long-oligo (70-mer) cDNA microarrays from the NCI/CCR
Microarray Center, NCI, Frederick, MD, according to standard protocols [</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B25"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>25</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>]. Hybridized arrays were analyzed using a <span
class=SpellE>GenePix</span> 4000B array scanner and <span class=SpellE>GenePix</span>
Pro 4.0 software (Axon Instruments, Molecular Devices Corporation). Data from <span
class=SpellE>GenePix</span> Pro 4.0 was uploaded to the microarray database at
the NCI/CCR Microarray Center website [</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B25"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>25</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>] for further analysis. Signal intensities of microarray
features were calculated by subtracting the median local background from the
median signal intensity. Features were considered for analysis if the signal
intensity was greater than one standard deviation above background with at
least a 2:1 signal-to-background ratio. Signal intensities for an entire
microarray were normalized to the 50% percentile median value. After filtering
and normalization, the Cy3 and Cy5 values were expressed as a ratio to indicate
the fold up- or down-regulation. Two independent experiments for each
comparison were performed, with a dye switch for each experiment, therefore
yielding four separate data sets. For determining gene expression changes
greater than or less than 2-fold, data sets were filtered for genes containing
at least two significant values out of four array sets. Prior to filtering, all
data points were analyzed using statistical analysis of microarray (SAM) data
and a resultant gene set was chosen at a delta value of 0.4 that limited the
false discovery rate (number of predicted false positive values/number of
significant genes) for each analysis to less than 1%. Minimal information about
a microarray experiment (MIAME)-compliant microarray data has been deposited
with the National Center for Biotechnology Information (NCBI) Gene Expression
Omnibus, accession number </span><a
href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE8916"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";display:none;
mso-hide:all;mso-ansi-language:EN'>{&quot;type&quot;:&quot;entrez-geo&quot;,&quot;attrs&quot;:{&quot;text&quot;:&quot;GSE8916&quot;,&quot;term_id&quot;:&quot;8916&quot;}}</span><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>GSE8916</span></a><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN'>, available at [</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B26"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>26</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>].</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Real-time RT-PCR analysis</span></b></p>

<p class=MsoNormal style='line-height:normal'><span class=GramE><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>cDNA</span></span><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'> was synthesized from RNA obtained for microarray
analysis using the <span class=SpellE>SuperScript</span>� III First-Strand
Synthesis System for RT-PCR (Invitrogen). Quantification of relative cDNA
levels for each gene was accomplished using the Platinum<sup>� </sup>SYBR<sup>�
</sup>Green qPCR <span class=SpellE>Supermix</span> UDG real-time RT-PCR kit
(Invitrogen) and a Rotor-Gene3000� thermocycler with Rotor-Gene 5.0.37 software
(Corbett Research) that calculates relative PCR synthesis rates by comparative
quantification. The specificity of product synthesis was verified by melting
curve analysis by the Rotor-Gene 5.0.37 software, and by running of real-time
PCR products on 2% agarose gels to verify product size and rule out
primer-dimer contribution to calculated values. The sequence-specific primers
used in real-time RT-PCR can be found in Additional file </span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#S2"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>2</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Cell cycle analysis</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>Cells grown
under anchorage-independent conditions were spun down, washed once in sterile
PBS, and suspended in a 50% mixture of PBS and ACCUMAX cell detachment solution
(<span class=SpellE>Chemicon</span> International) for 10 minutes at 25�C to
dissociate cell clumps. After dissociation, cells were washed once in cold PBS
and then fixed with 70% ethanol. Fixed cells were treated with <span
class=SpellE>RNAse</span> A for 20 minutes at 37�C, and nuclear DNA was stained
with 50 <span class=SpellE>&#956;g</span>/mL <span class=SpellE>propidium</span>
iodide at 4�C. Cell cycle profiles were generated using a <span class=SpellE>FACSCalibur</span>
flow cytometer (BD Biosciences) and modeling cell cycle phases with the cell
cycle option of <span class=SpellE>FlowJo</span> flow cytometry software (Tree
Star, Inc.) after gating for viable, single cells. Statistical analysis was
performed using 2-way ANOVA with Bonferroni post tests using the <span
class=SpellE>GraphPad</span> Prism software program (<span class=SpellE>GraphPad</span>
Software, Inc.).</span></p>

<p class=MsoNormal style='line-height:normal'><span class=SpellE><b><span
lang=EN style='font-size:13.5pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>EdU</span></b></span><b><span lang=EN style='font-size:
13.5pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'> cell
proliferation assay</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>Measurement
of cell proliferation by 5-ethynyl-2'-deoxyuridine (<span class=SpellE>EdU</span>)
incorporation was measured using the Click-<span class=SpellE>iT</span> <span
class=SpellE>EdU</span> cell proliferation Assay Kit for Flow Cytometry
(Invitrogen) according to the manufacturer's protocol. Briefly, cells were
plated at 1 � 10<sup>6 </sup>cells per well in 6-well ultra-low attachment
plates or 5 � 10<sup>5 </sup>cells per dish in 60 mm tissue culture dishes for
attached control cells. Attached cells were treated with either DMSO or 10 <span
class=SpellE>&#956;M</span> <span class=SpellE>EdU</span> for 4 hours, and
cells grown in low attachment plates were treated with DMSO or 10 <span
class=SpellE>&#956;M</span> <span class=SpellE>EdU</span> for 24 hours. Using <span
class=SpellE>FlowJo</span> flow cytometry software (Tree Star, Inc.),
DMSO-treated control cells were used to determine the threshold above which
cells could be considered <span class=SpellE>EdU</span> positive, and the
fraction of cells incorporating <span class=SpellE>EdU</span> was then
determined for experimental samples.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Cytotoxicity assay</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>The release
of lactose dehydrogenase (LDH) into cell culture supernatant was measured using
the cytotoxicity detection kit LDH (Roche Molecular <span class=SpellE>Biochemicals</span>)
according to the manufacturer's instructions.</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/"
title="Go to other sections in this page"><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN'>Go to:</span></a></p>

<div style='border:none;border-bottom:solid #97B0C8 1.0pt;padding:0in 0in 0in 0in'>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:18.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Results</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Generation of H-<span class=SpellE>Ras</span>- and <span class=SpellE>Rlf</span>-CAAX-expressing
HME16C cell lines</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>Retroviral
vectors coding for amino terminal HA-tagged activated H-Ras<sup>V12</sup>, the
H-Ras<sup>V12 </sup>effector domain mutants (EDM) H-Ras<sup>V12G37</sup>, H-Ras<sup>V12S35</sup>,
and H-Ras<sup>V12C40</sup>, and the constitutively activated version of a <span
class=SpellE>RalGEF</span>, <span class=SpellE>Rlf</span>-CAAX, were used to
infect telomerase immortalized HME16C human mammary epithelial cells. Anti-<span
class=SpellE>Ras</span> and anti-HA western blotting demonstrated approximately
equal levels of ectopic <span class=SpellE>Ras</span> expression among <span
class=SpellE>Ras</span>-infected cells, with slightly lower levels in HME16C
Ras<sup>V12</sup>-infected cells relative to EDM-infected cells (Figure </span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/figure/F1/"
target=figure><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>&#8203;</span><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN;text-decoration:
none;text-underline:none'>(Figure1A).</span><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>1A</span></a><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>). Analysis of activated, GTP-bound <span class=SpellE>Ral</span>
A demonstrated highly elevated levels of activated <span class=SpellE>Ral</span>
A only in <span class=SpellE>Rlf</span>-CAAX-expressing cells and not in <span
class=SpellE>Ras</span>-infected cells grown under standard culture conditions
(Figure </span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/figure/F1/"
target=figure><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>&#8203;</span><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN;text-decoration:
none;text-underline:none'>(Figure1B).</span><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>1B</span></a><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>). To assess activation of the ERK pathway, anti-<span
class=SpellE>phospho</span> <span class=SpellE>Erk</span> western blotting was
performed and showed significantly elevated <span class=SpellE>Erk</span>
phosphoprotein in Ras<sup>V12</sup>- and Ras<sup>V12S35</sup>-infected HME16C
cells relative to control <span class=SpellE>pLRT</span>-infected cells (Figure
</span><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/figure/F1/"
target=figure><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>&#8203;</span><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN;text-decoration:
none;text-underline:none'>(Figure1A).</span><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>1A</span></a><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>). Elevated levels of phosphorylated <span class=SpellE>Erk</span>
were also observed in Ras<sup>V12G37</sup>- and Ras<sup>V12C40</sup>-infected
cells, although at a much lower level than that found in Ras<sup>V12</sup>- and
Ras<sup>V12S35</sup>-infected cells. To assess activation of the PI3K signaling
pathway, anti-<span class=SpellE>phosphoAkt</span> (Ser473) western blotting
was performed to detect activated, phosphorylated <span class=SpellE>Akt</span>.
In cells that were serum starved for 24 hours and matrix detached for 6 hours,
elevated levels of phosphorylated <span class=SpellE>Akt</span> were observed
in Ras<sup>V12</sup>-, Ras<sup>V12C40</sup>-, and Ras<sup>V12G37</sup>-infected
HME16C, with highest levels present in Ras<sup>V12</sup>-infected cells (Figure
</span><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/figure/F1/"
target=figure><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>&#8203;</span><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN;text-decoration:
none;text-underline:none'>(Figure1C</span><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN'>1C</span></a><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>).</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/figure/F1/"
target=figure><span style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-no-proof:yes;text-decoration:none;text-underline:none'><img border=0
width=100 height=54 id="_x0000_i1035"
src="PMC2474852%20table%202_files/image004.gif" alt="Figure 1"></span></a></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/figure/F1/"
target=figure><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>Figure 1</span></a></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><b><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>Protein expression and pathway activation in HME16C cell
lines</span></b><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>. (A) Expression of HA-tagged H-Ras<sup>V12</sup>, H-Ras<sup>V12
</sup>effector domain mutants, and <span class=SpellE>Rlf</span>-CAAX in HME16C
mammary epithelial cells. In this and subsequent figures, cells infected with
the <span class=GramE>following <b>...</b></span></span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Anchorage-independent growth of mammary epithelial cell lines</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>To assess
transformation by different <span class=SpellE>Ras</span> signaling pathways,
anchorage-independent growth assays were performed in soft agar and in
ultra-low attachment tissue culture plates. <span class=SpellE>Ras</span>- and <span
class=SpellE>Ras</span> EDM-infected HME16C cells formed significantly more
soft agar colonies &gt;100 <span class=SpellE>&#956;m</span> in diameter than <span
class=SpellE>pLRT</span> vector-infected cells (Figure </span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/figure/F2/"
target=figure><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>&#8203;</span><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN;text-decoration:
none;text-underline:none'>(Figure2A).</span><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>2A</span></a><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>). The Ras<sup>V12</sup>-infected cells formed large
colonies, many exceeding 1000 <span class=SpellE>&#956;m</span>, although the
total number exceeding 100 <span class=SpellE>&#956;m</span> was typically less
than that for the <span class=SpellE>Ras</span> EDM (Figure </span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/figure/F2/"
target=figure><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>&#8203;</span><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN;text-decoration:
none;text-underline:none'>(Figure2B).</span><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>2B</span></a><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>). Among the <span class=SpellE>Ras</span> EDM-infected
cells, the Ras<sup>V12S35</sup>-infected cells formed the largest colonies.
These were similar to, but smaller than, the Ras<sup>V12</sup>-infected cells.
For colonies above 100 <span class=SpellE>&#956;m</span> in diameter, Ras<sup>V12C40</sup>-infected
cells were the most efficient at colony formation, despite the smaller mean
size of colonies. <span class=SpellE>Rlf</span>-CAAX-infected cells formed
slightly more colonies above 100 <span class=SpellE>&#956;m</span> than
vector-transfected control cells, but these were significantly smaller than
those formed by <span class=SpellE>Ras</span>- and <span class=SpellE>Ras</span>
EDM-infected cells.</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/figure/F2/"
target=figure><span style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-no-proof:yes;text-decoration:none;text-underline:none'><img border=0
width=100 height=68 id="_x0000_i1034"
src="PMC2474852%20table%202_files/image005.gif" alt="Figure 2"></span></a></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/figure/F2/"
target=figure><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>Figure 2</span></a></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span class=GramE><b><span lang=EN style='font-size:12.0pt;font-family:
"Times New Roman","serif";mso-ansi-language:EN'>Anchorage-independent growth of
HME16C cell lines</span></b><span lang=EN style='font-size:12.0pt;font-family:
"Times New Roman","serif";mso-ansi-language:EN'>.</span></span><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'> (A) Number of soft agar colonies exceeding 100 <span class=SpellE>&#956;M</span>
after 21 days of growth for HME16C cell lines infected with <span class=SpellE>pLRT</span>
control, H-Ras<sup>V12</sup>, H-Ras<sup>V12G37</sup>, H-Ras<sup>V12S35</sup>, H-Ras<sup>V12C40</sup>,
and <span class=SpellE>Rlf</span>-CAAX-expressing <b>...</b></span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>When grown
under anchorage-independent conditions in ultra-low attachment plates, the
accumulation of cells for the various infected cell lines roughly paralleled
the total cell masses seen in soft agar growth assays (Figure </span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/figure/F2/"
target=figure><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>&#8203;</span><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN;text-decoration:
none;text-underline:none'>(Figure2C).</span><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>2C</span></a><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>). The Ras<sup>V12</sup>- and Ras<sup>V12 </sup>EDM-expressing
cells grew well, while the growth of the <span class=SpellE>Rlf</span>-CAAX-expressing
cells was significantly less. The HME16C cells maintained viability but did not
increase in number.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>To compare
our results to others, we verified the function of <span class=SpellE>pLRT</span>
vector driven <span class=SpellE>Ras</span> EDM mutants and <span class=SpellE>Rlf</span>-CAAX
in HEK-HT cells, which previously have been reported to form colonies in soft
agar upon expression of H-Ras<sup>V12G37 </sup>and <span class=SpellE>Rlf</span>-CAAX
[</span><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B27"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>27</span></a><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN'>]. In our hands,
expression of H-Ras<sup>V12</sup>, H-Ras<sup>V12G37</sup>, and <span
class=SpellE>Rlf</span>-CAAX from the <span class=SpellE>pLRT</span> vector
induced efficient soft agar colony growth, and H-Ras<sup>V12S35 </sup>and H-Ras<sup>V12C40
</sup>did not (not shown), identical to previously reported results [</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B27"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>27</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>]. Expression of exogenous H-<span class=SpellE>Ras</span>
and <span class=SpellE>Rlf</span>-CAAX, and activation of endogenous <span
class=SpellE>RalA</span>, in this cell line was similar to that observed in
HME16C cells (not shown). Therefore, expression of <span class=SpellE>Rlf</span>-CAAX
and subsequent <span class=SpellE>RalA</span> activation did not appear to be
sufficient to induce anchorage-independent growth in the HME16C mammary
epithelial cell line in contrast to HEK-HT and various other immortalized human
cell types [</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B27"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>27</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>].</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Tumorigenesis of HME16C cell lines in nude mice</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>Anchorage-independent
growth often predicts the ability of cells to grow as <span class=SpellE>xenografted</span>
tumors in immuno-compromised mice. Tumor formation was assessed following
subcutaneous inoculation. The Ras<sup>V12</sup>-infected HME16C cells formed
rapidly growing, fluid-filled tumors with an average latency of 4 weeks and a
mean tumor volume of 808.8 mm<sup>3 </sup>at 6 weeks (Table </span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/table/T1/"
target=true><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>&#8203;</span><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN;text-decoration:
none;text-underline:none'>(Table1).</span><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN'>1</span></a><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>). Approximately one-half of the tumors were aspirated
prior to sacrifice, and a <span class=SpellE>sero-sanguinous</span> fluid was
observed, on average accounting for roughly one-third of the measured tumor
volume. Histological analysis of H&amp;E stained tumor sections revealed poorly
differentiated spindle-shaped tumor cells with prominent squamous cell
differentiation and extracellular keratin deposition (not shown). Tumors also
contained a strong inflammatory component. Of the other cell lines tested, only
the Ras<sup>V12S35</sup>-infected HME16C cells formed palpable tumors in 50% of
injected animals with an average latency of approximately 12 weeks and a mean
tumor volume of 109.0 mm<sup>3 </sup>at 16 weeks, considerably smaller than Ras<sup>V12</sup>-expressing
tumors (Table </span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/table/T1/"
target=true><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>&#8203;</span><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN;text-decoration:
none;text-underline:none'>(Table1).</span><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN'>1</span></a><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>). Cells within Ras<sup>V12S35</sup>-infected tumors
resembled the histology of Ras<sup>V12 </sup>tumor cells but with less keratin
deposition and without the formation of fluid-filled spaces (not shown). Empty
vector-, Ras<sup>V12G37</sup>-, Ras<sup>V12C40</sup>-, and <span class=SpellE>Rlf</span>-CAAX-infected
cells failed to form palpable tumors four months after injection. The
metastatic potential of Ras<sup>V12</sup>- and Ras<sup>V12G37</sup>-expressing
cell lines was tested by tail-vein injection in nude mice, but no metastatic
lesions were observed by histological analysis in lungs, liver, spleen, or
kidneys at 16 weeks post injection (not shown).</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/table/T1/"
target=table><span style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-no-proof:yes;text-decoration:none;text-underline:none'><img border=0
width=204 height=142 id="_x0000_i1033"
src="PMC2474852%20table%202_files/image006.png" alt="Table 1"></span></a></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/table/T1/"
target=table><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>Table 1</span></a></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>Growth of HME16C tumors in nude mice</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Autocrine EGFR signaling is required for Ras<sup>V12G37</sup>- and Ras<sup>V12C40</sup>-mediated,
but not Ras<sup>V12S35</sup>-mediated, HME16C cell anchorage- independent
growth</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>EGFR
signaling is frequently altered in breast cancer, where EGFR and ErbB2 over-expression
are common events. <span style='background:yellow'>cDNA microarray and
real-time RT-PCR analysis of HME16C Ras<sup>V12</sup>- and <span class=SpellE>Ras</span>
EDM-infected cells (Additional file <a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#S1">1</a>)
revealed increased levels of mRNAs for EGFR ligands, including <span
class=SpellE>epiregulin</span>, <span class=SpellE>amphiregulin</span>, and <span
class=SpellE>TGFa</span> (Table <a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/table/T2/"
target=true>&#8203;2</a>).</span> <span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
background:yellow;mso-highlight:yellow;mso-shading:yellow;mso-ansi-language:
EN'>In addition, increased levels of <span
class=SpellE>phospho-Erk</span> were unexpectedly seen in Ras<sup>V12G37</sup>-
and Ras<sup>V12C40</sup>-infected cells, possibly the result of autocrine
activation of endogenous EGFR by secreted EGFR ligands.</span><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'> The presence of EGFR was established using Western blots (not shown). <span
style='background:yellow'>Therefore, we sought to determine if autocrine
signaling by the EGFR was required for the anchorage-independent growth of <span
class=SpellE>Ras</span>- or <span class=SpellE>Ras</span> EDM-infected cells.</span>
<span style='background:yellow'>Ras<sup>V12</sup>- and <span class=SpellE>Ras</span>
EDM-infected HME16C cells were grown in soft agar in the presence or absence of
the EGFR-specific inhibitors, PD153035 and PD168393.</span> Complete inhibition
of colony formation for Ras<sup>V12G37</sup>-infected and Ras<sup>V12C40</sup>-infected
cells was observed at 0.25 <span class=SpellE>&#956;M</span> PD153035, a
concentration that specifically inhibits EGFR [</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B28"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>28</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>], whereas both the Ras<sup>V12</sup>- and Ras<sup>V12S35</sup>-infected
cells formed colonies efficiently at this same concentration of inhibitor
(Figure </span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/figure/F3/"
target=figure><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>&#8203;</span><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN;text-decoration:
none;text-underline:none'>(Figure3A</span><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN'>3A</span></a><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'> and </span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/figure/F3/"
target=figure><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>&#8203;</span><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN;text-decoration:
none;text-underline:none'>and3B).</span><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN'>3B</span></a><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>). Identical results were found for the EGFR-specific
inhibitor PD168393 used at 0.1 <span class=SpellE>&#956;M</span>, a
concentration that specifically inhibits EGFR and Her-2 receptors [</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B29"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>29</span></a><span class=GramE><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN'>](</span></span><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>not shown). Similarly, treatment of cells grown in
ultra-low-attachment plates also demonstrated that EGFR inhibition
substantially inhibited growth of Ras<sup>V12G37</sup>-and Ras<sup>V12C40</sup>-expressing
cells relative to that of Ras<sup>V12</sup>- and Ras<sup>V12S35</sup>-expressing
HME16C (Figure </span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/figure/F2/"
target=figure><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>&#8203;</span><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN;text-decoration:
none;text-underline:none'>(Figure2C).</span><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>2C</span></a><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>). Western blotting of cellular lysates from cells
treated with 0.25 <span class=SpellE>&#956;M</span> PD153035 showed that high
levels of phosphorylated <span class=SpellE>Erk</span> were maintained only in
Ras<sup>V12</sup>- and Ras<sup>V12S35</sup>-infected cells, but were
significantly reduced in Ras<sup>V12G37</sup>- or Ras<sup>V12C40</sup>-infected
cells treated with the inhibitor (Figure </span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/figure/F3/"
target=figure><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>&#8203;</span><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN;text-decoration:
none;text-underline:none'>(Figure3C),</span><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>3C</span></a><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>), while <span class=SpellE>phoshorylated</span> <span
class=SpellE>Akt</span> was minimally affected (not shown).
Anchorage-independent growth therefore correlated with maintenance of high <span
class=SpellE>Erk</span> activity in HME16C cells. Consistent with this
observation, inhibition of MEK, and therefore ERK signaling, using the
MEK-specific inhibitor PD98059 at 10 <span class=SpellE><span class=GramE>&#956;M</span></span><span
class=GramE>,</span> significantly inhibited soft agar colony formation by all
cell lines (not shown).</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/table/T2/"
target=table><span style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-no-proof:yes;text-decoration:none;text-underline:none'><img border=0
width=204 height=108 id="_x0000_i1032"
src="PMC2474852%20table%202_files/image007.png" alt="Table 2"></span></a></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/table/T2/"
target=table><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>Table 2</span></a></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>Up-regulation of EGFR ligands in Ras<sup>V12</sup>- and <span
class=SpellE>Ras</span> EDM-expressing HME16C</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/figure/F3/"
target=figure><span style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-no-proof:yes;text-decoration:none;text-underline:none'><img border=0
width=100 height=59 id="_x0000_i1031"
src="PMC2474852%20table%202_files/image008.gif" alt="Figure 3"></span></a></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/figure/F3/"
target=figure><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>Figure 3</span></a></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span class=GramE><b><span lang=EN style='font-size:12.0pt;font-family:
"Times New Roman","serif";mso-ansi-language:EN'>Anchorage-independent growth of
HME16C cell lines after EGFR inhibition</span></b><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>.</span></span><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'> (A) Cell lines, as indicated, were grown in the soft
agar assay for 21 days either in the presence of DMSO vehicle or 0.25 <span
class=SpellE>&#956;M</span> PD153035 EGFR inhibitor. Scale bar, 200 <span
class=SpellE>&#956;m</span>. <b>...</b></span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Microarray analysis of gene expression changes in Ras<sup>V12</sup>-, Ras<sup>V12G37</sup>-,
Ras<sup>V12S35</sup>-, and Ras<sup>V12C40</sup>-infected HME16C cells</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>Activation
of the <span class=SpellE>Ras</span> oncogene is accompanied by the stimulation
of multiple signal transduction pathways leading to the activation or
repression of numerous transcription factors as well as changes in mRNA
translation and stability, and thus, the modulation of gene expression. To
determine which gene expression changes accompany the transformation of HME16C
human epithelial cells by activated <span class=SpellE>Ras</span>, we examined
our transformed HME16C cells by cDNA microarray analysis. To do this, RNA was
isolated from H-Ras<sup>V12 </sup>and H-Ras<sup>V12 </sup>EDM expressing cells
after treatment with doxycycline to fully induce gene expression and compared
to RNA from identically treated <span class=SpellE>pLRT</span> vector-infected
control cells. Statistical analysis of microarray (SAM) data analysis was
performed for the datasets, and a delta value of 0.4 was chosen for each
dataset, which maintains the estimated false discovery rate (FDR) below 1% for
each. A summary of the genes up- or down-regulated greater than 2-fold in the
H-Ras<sup>V12</sup>- and <span class=SpellE>Ras</span> effector domain
mutant-infected HME16C cell lines is presented in Additional file </span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#S1"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>1</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>, organized according to broad categories of gene
function. To validate gene expression changes identified by cDNA microarray
analysis, quantitative RT-PCR was performed using RNA from the same samples
used in microarray analysis, and is presented in Additional file </span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#S2"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>2</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>. Results for 22 of 26 genes chosen to reflect genes up-
or down-regulated both strongly or weakly showed strong agreement with
microarray data, demonstrating that the microarray dataset represents a
reliable quantification of gene expression changes.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>To evaluate
the effect of EGFR inhibition on gene expression, Ras<sup>V12</sup>-, Ras<sup>V12S35</sup>-,
and Ras<sup>V12G37</sup>-infected cells were induced with doxycycline and
subsequently incubated either in the presence or absence of 0.25 <span
class=SpellE>&#956;M</span> PD153035, and microarray analysis comparisons were
made to vehicle-treated <span class=SpellE>pLRT</span>-infected cells. Almost
all <span class=SpellE>Ras</span> and <span class=SpellE>Ras</span> EDM-induced
upregulated transcriptional responses were blocked by pharmacological
inhibition of EGFR, consistent with previous reports for inhibition of <span
class=SpellE>Raf</span>-regulated transcription [</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B30"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>30</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>]. Our analysis identified PHLDA1 as an up-regulated gene
in both vehicle-treated and PD153035-treated Ras<sup>V12 </sup>and Ras<sup>V12S35
</sup>cells, although the relative fold increase was reduced following EGFR
inhibition. By comparison, PHLDA1 was down-regulated in PD153035-treated Ras<sup>V12G37
</sup>relative to vehicle-treated cells (not shown). Therefore, PHLDA1
represents a <span class=SpellE>Raf</span>/ERK-responsive gene whose expression
parallels EGFR-independent HME16C mammary epithelial cell transformation.</span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>TDAG51 expression is up-regulated by <span class=SpellE>Ras</span>
signaling in a ERK-dependent manner, and is associated with EGFR-independent
transformation</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>The PHLDA1
gene is of interest as it has been suggested to be a tumor suppressor in breast
adenocarcinoma and melanoma [</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B17"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>17</span></a><span class=GramE><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN'>,</span></span><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B18">18</a>]. We
further analyzed the signal dependent expression of the PHLDA1 gene and its
protein product, TDAG51. Microarray analysis identified the PHLDA1 gene as
being dramatically up-regulated in Ras<sup>V12</sup>- and <span class=SpellE>Ras</span>
EDM-infected cells to levels that correlated with the level of ERK activation
and the extent of anchorage-independent growth (Additional file </span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#S1"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>1</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>). Western blotting confirmed that TDAG51 was also
upregulated in a similar manner (Figure </span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/figure/F4/"
target=figure><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>&#8203;</span><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN;text-decoration:
none;text-underline:none'>(Figure4A).</span><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>4A</span></a><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>). The PHLDA1 gene was elevated in PD153035-treated Ras<sup>V12</sup>-
and Ras<sup>V12S35</sup>-infected cells but was significantly dependent upon
EGFR tyrosine kinase activity for upregulation in Ras<sup>V12G37</sup>- and Ras<sup>V12C40</sup>-infected
cells (not shown), and the expression of the encoded TDAG51 protein
approximately paralleled PHLDA1 RNA expression (Figure </span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/figure/F4/"
target=figure><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>&#8203;</span><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN;text-decoration:
none;text-underline:none'>(Figure4B).</span><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>4B</span></a><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>). As shown in Figure </span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/figure/F3/"
target=figure><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>&#8203;</span><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN;text-decoration:
none;text-underline:none'>Figure3C<span class=GramE>,<u>3C</u></span></span></a><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>, EGFR inhibition significantly reduced ERK signaling in
Ras<sup>V12G37</sup>- and Ras<sup>V12C40</sup>-infected cells without affecting
Ras<sup>V12</sup>- and Ras<sup>V12S35</sup>-infected cells. To confirm that
TDAG51 up-regulation was induced specifically by ERK activation, we treated <span
class=SpellE>pLRT</span>-, Ras<sup>V12</sup>-, and Ras<sup>V12S35</sup>-infected
cells with the MEK-specific inhibitor PD98059. PD98059 used at 20 <span
class=SpellE>&#956;M</span> appears to be specific for MEK1 as it does not
nonspecifically inhibit a variety of other protein kinases that have been
assayed. [</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B31"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>31</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>]. TDAG51 up-regulation was attenuated by MEK inhibition
(Figure </span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/figure/F5/"
target=figure><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>&#8203;</span><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN;text-decoration:
none;text-underline:none'>(Figure5).</span><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN'>5</span></a><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>). TDAG51 therefore represents an ERK-inducible gene
whose up-regulation in HME16C is correlated with an EGFR-independent,
ERK-mediated transformation.</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/figure/F4/"
target=figure><span style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-no-proof:yes;text-decoration:none;text-underline:none'><img border=0
width=100 height=100 id="_x0000_i1030"
src="PMC2474852%20table%202_files/image009.gif" alt="Figure 4"></span></a></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/figure/F4/"
target=figure><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>Figure 4</span></a></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span class=GramE><b><span lang=EN style='font-size:12.0pt;font-family:
"Times New Roman","serif";mso-ansi-language:EN'>Expression of TDAG51 in HME16C
cell lines in the absence or presence of the EGFR <span class=SpellE>inibition</span></span></b><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>.</span></span><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN'> <span class=GramE>Western
blotting of TDAG51 in HME16C cell lines.</span> (A) Twenty-five micrograms of
protein from HME16C cellular lysates were resolved by SDS-PAGE and probed with <span
class=GramE>an <b>...</b></span></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/figure/F5/"
target=figure><span style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-no-proof:yes;text-decoration:none;text-underline:none'><img border=0
width=100 height=49 id="_x0000_i1029"
src="PMC2474852%20table%202_files/image010.gif" alt="Figure 5"></span></a></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/figure/F5/"
target=figure><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>Figure 5</span></a></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><b><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>TDAG51 expression is induced by ERK pathway activation</span></b><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>. HME16C cell lines infected with <span class=SpellE>pLRT</span>
empty vector (<span class=SpellE>pLRT</span>), Ras<sup>V12 </sup>(V12), or Ras<sup>V12S35
</sup>(S35) were treated with 0.2% DMSO vehicle or 20 <span class=SpellE>&#956;M</span>
PD98059 for 24 hours, followed by western <span class=GramE>blotting <b>...</b></span></span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>TDAG51 up-regulation opposes ERK-mediated HME16C transformation</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>To analyze
the role of TDAG51 in ERK-dependent growth, we reduced TDAG51 expression in Ras<sup>V12</sup>-
and Ras<sup>V12S35</sup>-infected cells to a level comparable to that in
non-transformed vector-infected control cells using stably expressed
TDAG51-specific shRNA (Figure </span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/figure/F6/"
target=figure><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>&#8203;</span><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN;text-decoration:
none;text-underline:none'>(Figure6A).</span><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>6A</span></a><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>). Cell proliferation of attached cells grown on tissue
culture plastic was unaffected by lowered TDAG51 protein levels (not shown).
However, cell growth under anchorage-independent conditions in ultra-low
attachment plates was significantly enhanced by TDAG51 knock-down in Ras<sup>V12S35</sup>-infected
cells (Figure </span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/figure/F6/"
target=figure><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>&#8203;</span><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN;text-decoration:
none;text-underline:none'>(Figure6B).</span><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>6B</span></a><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>). Likewise, results with Ras<sup>V12</sup>-infected
cells stably infected with TDAG51-targeting shRNA also showed enhanced growth
relative to vector-infected control cells, although to a lesser extent than
that seen with Ras<sup>V12S35</sup>-infected cells (Figure </span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/figure/F6/"
target=figure><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>&#8203;</span><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN;text-decoration:
none;text-underline:none'>(Figure6C).</span><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>6C</span></a><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>). This suggests that <span class=SpellE>Ras</span>
signaling pathways other than ERK compensate partially for the negative growth
effects of TDAG51, or that Ras<sup>V12</sup>-infected cells are already close
to maximally transformed under anchorage-independent growth conditions.</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/figure/F6/"
target=figure><span style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-no-proof:yes;text-decoration:none;text-underline:none'><img border=0
width=100 height=43 id="_x0000_i1028"
src="PMC2474852%20table%202_files/image011.gif" alt="Figure 6"></span></a></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/figure/F6/"
target=figure><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>Figure 6</span></a></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span class=GramE><b><span lang=EN style='font-size:12.0pt;font-family:
"Times New Roman","serif";mso-ansi-language:EN'>Reduction of TDAG51 expression in
Ras<sup>V12 </sup>and Ras<sup>V12S35</sup>-infected cells and their
anchorage-independent growth</span></b><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN'>.</span></span><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'> (A) Western blotting of TDAG51 protein (TDAG51) from 5 <span
class=SpellE>&#956;g</span> of cellular lysates from non-silencing vector
control (<span class=SpellE>pLVTHM</span>) and anti-<span class=GramE>TDAG51 <b>...</b></span></span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Loss of TDAG51 expression in transformed cells stimulates both cell cycle
progression and apoptosis</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>To
characterize the effect of TDAG51 on cell proliferation under
anchorage-independent conditions, cell cycle analysis and cell proliferation
assays for Ras<sup>V12S35</sup>- and Ras<sup>V12</sup>-infected cells were
performed. Both Ras<sup>V12S35</sup>- and Ras<sup>V12</sup>- TDAG51
shRNA-expressing cells demonstrated an increased S-phase fraction versus <span
class=SpellE>pLVTHM</span> vector control cells at various time points during
anchorage-independent growth (Figure </span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/figure/F7/"
target=figure><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>&#8203;</span><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN;text-decoration:
none;text-underline:none'>(Figure7A).</span><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>7A</span></a><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>). In concordance with these results, Ras<sup>V12S35 </sup>and
Ras<sup>V12 </sup>cells expressing the TDAG51-specific shRNA showed enhanced
incorporation of 5-ethynyl-2'-deoxyuridine (<span class=SpellE>EdU</span>) in
cell proliferation assays, indicating a higher rate of DNA synthesis in cells
with reduced TDAG51 protein (Figure </span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/figure/F7/"
target=figure><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>&#8203;</span><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN;text-decoration:
none;text-underline:none'>(Figure7C</span><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN'>7C</span></a><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>).</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/figure/F7/"
target=figure><span style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-no-proof:yes;text-decoration:none;text-underline:none'><img border=0
width=100 height=73 id="_x0000_i1027"
src="PMC2474852%20table%202_files/image012.gif" alt="Figure 7"></span></a></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/figure/F7/"
target=figure><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>Figure 7</span></a></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><b><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>Cell proliferation is increased in <span class=SpellE>Ras</span>-transformed
cell lines with reduced TDAG51 expression</span></b><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>. (A) S phase fraction of Ras<sup>V12S35</sup>-expressing (left panel) or
Ras<sup>V12</sup>-expressing (right panel) HME16C infected with <span
class=SpellE>pLVTHM</span> non-silencing vector control or anti-<span
class=GramE>TDAG51 <b>...</b></span></span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>Since cell
growth under anchorage-independent conditions is a balance between cell
proliferation and cell death, we sought to evaluate the effect upon cellular
death of TDAG51 knock-down. We used an assay of cellular cytotoxicity that
measures the release of the lactose <span class=SpellE>deydrogenase</span>
enzyme, LDH. LDH release was increased by TDAG51 shRNA-expressing Ras<sup>V12S35
</sup>cells relative to <span class=SpellE>pLVTHM</span>-infected cells at
various time points after the initiation of matrix-detached growth (Figure </span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/figure/F8/"
target=figure><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>&#8203;</span><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN;text-decoration:
none;text-underline:none'>(Figure8).</span><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN'>8</span></a><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>). The difference in LDH release for TDAG51
shRNA-expressing Ras<sup>V12 </sup>cells was minimal and rarely approached
statistical significance. Sub-G1 peaks indicative of dead cells were sometimes
seen with cell cycle analysis at late time points, but varied from experiment
to experiment. Therefore, for Ras<sup>V12S35</sup>-infected cells, the
differences in cell growth after TDAG51 reduction under anchorage-independent
conditions resulted from an enhanced rate of cellular proliferation that
exceeded a concomitant increase in cell death.</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/figure/F8/"
target=figure><span style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-no-proof:yes;text-decoration:none;text-underline:none'><img border=0
width=100 height=38 id="_x0000_i1026"
src="PMC2474852%20table%202_files/image013.gif" alt="Figure 8"></span></a></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/figure/F8/"
target=figure><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>Figure 8</span></a></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><b><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>LDH release by Ras<sup>V12S35</sup>- or Ras<sup>V12</sup>-expressing
HME16C infected with <span class=SpellE>pLVTHM</span> vector or anti-TDAG51
shRNA 36-1</span></b><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>. (A) Relative LDH activity released by <span
class=SpellE>pLVTHM</span>- or anti-TDAG51 shRNA 36-1-infected Ras<sup>V12S35 </sup>cells
was measured in the culture media of cells <span class=GramE>grown <b>...</b></span></span></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:13.5pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Reduction of TDAG51 in transformed cells enhances proximal ERK signaling</span></b></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>Reducing
TDAG51 protein levels in ERK-driven cellular transformation enhanced cell
growth under anchorage-independent, but not attached, conditions. To test
whether TDAG51 might affect proximal ERK signaling, we examined the activation
status of <span class=SpellE>Erk</span> in cells expressing TDAG51-specific
shRNA. Interestingly, the levels of phosphorylated <span class=SpellE>Erk</span>
were enhanced when TDAG51 protein levels were reduced in Ras<sup>V12S35 </sup>and
Ras<sup>V12 </sup>cells grown under anchorage-independent, but not attached,
conditions (Figure </span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/figure/F9/"
target=figure><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>&#8203;</span><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN;text-decoration:
none;text-underline:none'>(Figure9).</span><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN'>9</span></a><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>). The fact that the activation status of <span
class=SpellE>Erk</span> was unchanged in cells grown under attached conditions
suggests that reducing TDAG51 expression had no selective effect with regard to
ERK activation in these cells. Rather, the enhanced activation of <span
class=SpellE>Erk</span> was specific to anchorage-independent growth
conditions.</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/figure/F9/"
target=figure><span style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-no-proof:yes;text-decoration:none;text-underline:none'><img border=0
width=100 height=59 id="_x0000_i1025"
src="PMC2474852%20table%202_files/image014.gif" alt="Figure 9"></span></a></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/figure/F9/"
target=figure><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>Figure 9</span></a></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><b><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>ERK pathway activation in Ras<sup>V12 </sup>and Ras<sup>V12S35
</sup>cells infected with <span class=SpellE>pLVTHM</span> or anti-TDAG51 shRNA
36-1</span></b><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>. Ras<sup>V12 </sup>or Ras<sup>V12S35 </sup>cells
infected with either <span class=SpellE>pLVTHM</span> vector control or
anti-TDAG51 shRNA 36-1 were grown for 72 hours attached to tissue culture <span
class=GramE>plastic <b>...</b></span></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/"
title="Go to other sections in this page"><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN'>Go to:</span></a></p>

<div style='border:none;border-bottom:solid #97B0C8 1.0pt;padding:0in 0in 0in 0in'>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:18.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Discussion</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span class=SpellE><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Ras</span></span><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'> is a common signaling node for various cell surface
receptors that contribute to epithelial cell transformation [</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B14"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>14</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>]. In this study, we used the hTERT-immortalized human
mammary epithelial cell line HME16C to examine which <span class=SpellE>Ras</span>
signaling pathways are sufficient for transformation and to identify
transcriptional targets downstream of those pathways that might modulate this
phenotype. Transduction of HME16C with pathway-discriminating <span
class=SpellE>Ras</span> effector domain mutants demonstrated that multiple
downstream <span class=SpellE>Ras</span> signal transduction pathways
contribute to anchorage-independent growth including <span class=SpellE>Raf</span>-,
<span class=SpellE>RalGEF</span>-, and PI3K-mediated signaling. <span
class=GramE>Transformation of HME16C by the Ras<sup>V12G37 </sup>effector
domain mutant but not activated <span class=SpellE>Rlf</span>-CAAX suggest</span>
that Ras<sup>V12G37</sup>-binding effectors other than <span class=SpellE>RalGEF</span>
contribute to mammary epithelial transformation.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>Microarray
analyses of Ras<sup>V12 </sup>and <span class=SpellE>Ras</span> effector domain
mutant transduced cells demonstrated a common upregulation of EGFR ligands
among transformed cell lines. This suggested that autocrine EGFR ligand secretion
was an important component of <span class=SpellE>Ras</span>-mediated cellular
transformation. Following blockade of EGFR signaling with the EGFR-specific
inhibitor PD153035, the only pathway downstream of <span class=SpellE>Ras</span>
that promoted anchorage-independent growth was <span class=SpellE>Raf</span>/ERK,
suggesting that <span class=SpellE><span class=GramE>Raf</span></span>
activation was able to substitute for EGFR activity in this cell line. In
contrast, previous studies with MCF10A cells demonstrated that EGFR tyrosine
kinase activity was necessary to inhibit <span class=SpellE>anoikis</span> upon
matrix detachment, even in cells expressing activated <span class=SpellE><span
class=GramE>Raf</span></span> [</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B16"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>16</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>]. By contrast, under matrix detached conditions, the
parental HME16C cells are non-proliferative, but do not actively undergo <span
class=SpellE>anoikis</span>. The studies here measure a proliferative response
of <span class=SpellE>Raf</span>/ERK activation in the absence of a strong
apoptotic component. In addition, blockade of MEK activity with the
MEK-specific inhibitor PD98059 prevented the transformation of Ras<sup>V12</sup>-
and Ras<sup>V12S35</sup>-expressing cells. This, taken together with the
finding that Ras<sup>V12</sup>- and Ras<sup>V12S35</sup>-transduced HME16C
cells were able to form tumors in nude mice, indicates that the <span
class=SpellE>Raf</span>-MEK-<span class=SpellE>Erk</span> axis plays a crucial
role in mediating transformation and tumorigenesis in this model. However, it
should be noted that <span class=SpellE>Ras</span>-transformed HME16C, as well
as the similar HMLER [</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B32"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>32</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>], give rise to squamous <span class=SpellE>metaplasias</span>
and not adenocarcinomas. It has been hypothesized that HMLE human mammary
epithelial cells represent a distinct precursor population from those mammary
epithelial cells that give rise to glandular adenocarcinomas, the predominant
form of breast cancer [</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B32"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>32</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>].</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>The
significantly reduced <span class=SpellE>tumorigenicity</span> of Ras<sup>V12S35</sup>-
as compared to Ras<sup>V12</sup>- expressing cells emphasizes the importance of
cooperation between <span class=SpellE>Ras</span> signal transduction pathways
for a fully transformed phenotype. Following EGFR inhibition, Ras<sup>V12C40</sup>-
and Ras<sup>V12G37</sup>- transduced lines lost anchorage-independent growth,
suggesting that non-ERK signaling pathways contribute to cellular
transformation through an EGFR dependent mechanism. Indeed, one consequence of
EGFR activation is ERK pathway activation and may explain the role of EGFR in
cooperating with Ras<sup>V12G37</sup>- and Ras<sup>V12C40</sup>-mediated cell
signaling to promote anchorage-independent growth.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>Microarray
analyses identified up-regulation of the PHLDA1 gene product as being
correlated with ERK-mediated cellular transformation. Likewise, the protein
product of the PHLDA1 gene, TDAG51, displayed an identical expression pattern.
Expression of PHLDA1 mRNA and TDAG51 protein in breast cancer has recently been
described [</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B17"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>17</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>]. Using TDAG51 immunohistochemistry of tissue
microarrays, 699 individual primary invasive breast tumor specimens were
examined; loss of TDAG51 was found to correlate with a poorer disease-free and
overall survival rate in multivariate analysis. Similar results have been found
in a small series of melanomas, where TDAG51 immunoreactivity was found to
decrease during the progression of melanocytic nevi to primary melanomas and
finally to metastatic melanoma [</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B18"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>18</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>]. These studies suggest that TDAG51 has a suppressive
effect on tumor progression and prompted us to evaluate the cell biological
function of TDAG51 in the HME16C transformation model.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>The PHLDA1
gene is a member of the <span class=SpellE>pleckstrin</span> homology-related
domain family that includes <span class=SpellE>Ipl</span>/<span class=SpellE>Tssc</span>
and <span class=SpellE>Tih</span> [</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B33"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>33</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>]. PHDLA1 has been described as an immediate early gene
with transcriptional activation resulting from engagement of receptors such as
the FGF and IGF tyrosine kinase receptors and the T-cell receptor [</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B34"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>34</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>-</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B36"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>36</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>]. Strong TDAG51 induction by Ras<sup>V12S35 </sup>transformation
of mammary epithelial cells suggests that ERK activation may at least partially
explain TDAG induction in these previous reports. <i>In vitro </i>studies have suggested
a role for TDAG51 in the control of cellular proliferation and in the induction
of apoptosis in response to a variety of stresses including <span class=SpellE>proteotoxic</span>
cellular stresses such as lung cancer cell responses to <span class=GramE>chemotherapy[</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B35">35</a>,</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B37"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>37</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>-</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B39"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>39</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>].</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>Overexpression
of TDAG51 has been shown to reduce cell proliferation and induce cell death in
a variety of cell types including T cells, neuronal, endothelial, melanoma, and
cervical carcinoma cell types [</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B34"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>34</span></a><span class=GramE><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN'>,</span></span><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B35">35</a>,</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B38"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>38</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>]. By contrast, TDAG51 functioned as an anti-apoptotic
factor downstream of insulin-like growth factor receptor (IGFR) signaling as
TDAG51 was required to protect NIH3T3 cells from apoptosis upon IGF-1
withdrawal [</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B36"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>36</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>].</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>Reduction of
TDAG51 levels in Ras<sup>V12 </sup>and Ras<sup>V12S35 </sup>cells enhanced cell
proliferation under anchorage-independent conditions. This suggests that TDAG51
expression limits cellular proliferation. In addition to enhancing cellular
proliferation, reduction of TDAG51 protein levels also increased the absolute
amount of cell death in transformed Ras<sup>V12S35 </sup>cells under these same
conditions. Therefore, TDAG51 loss, in the context of oncogene activation, may
indirectly promote cell death as a consequence of enhanced cell cycling.
However, the overall increased cell numbers in anchorage-independent conditions
showed that enhanced cellular proliferation exceeded enhanced cell death.</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>Interestingly,
a decrease in TDAG51 expression during <span class=SpellE>Ras</span>-mediated
cellular transformation promoted the growth of cells under
anchorage-independent conditions but did not affect the growth of attached
cells. This suggests that TDAG51 might act in conjunction with both cellular <span
class=GramE>stress</span>, in this case matrix detachment, and a proliferative
signal, in this case oncogenic activation. Other studies also have implicated
TDAG51 in functioning during cellular stress and survival, particularly
endoplasmic reticulum stress associated with the unfolded protein response [</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B37"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>37</span></a><span class=GramE><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN'>,</span></span><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B38">38</a>]. A
mechanism of action for TDAG51 is not known. The preliminary finding that
TDAG51 binds to proteins involved in protein translation has been used to suggest
that TDAG51 may play a role in regulating protein synthesis in response to <span
class=SpellE>proteotoxic</span> stress [</span><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/#B40"><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>40</span></a><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>].</span></p>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>Reduction of
TDAG51 expression resulted in an increase in <span class=SpellE>Erk</span>
activation in cells grown under anchorage-independent conditions. How TDAG51
expression might suppress ERK signaling is not known, but appears to represent
a negative feedback pathway that directly or indirectly limits ERK activation.
This is not likely to be due to an inhibition of ERK protein synthesis by
TDAG51, since Erk2 levels were unaffected by reduced TDAG51. However, another
important component of ERK activation is the dual specific ERK phosphatases, a
highly regulated class of proteins, whose relative level of activity may be
affected by TDAG51 protein levels. Understanding the mechanisms by which TDAG51
regulates ERK pathway activation and the balance between cellular proliferation
and apoptosis of transformed cells represents a future challenge. Finally,
TDAG51 acts in a suppressive manner during matrix-detached growth of HME16C
cells. Taken together with the identification of TDAG51 as a stress-induced
gene in a variety of cell lines and a growth inhibitor in melanoma cell lines,
it is reasonable to suggest that loss of TDAG51 may act to promote progression
of breast cancer through an intrinsic growth regulatory mechanism.</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/"
title="Go to other sections in this page"><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN'>Go to:</span></a></p>

<div style='border:none;border-bottom:solid #97B0C8 1.0pt;padding:0in 0in 0in 0in'>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:18.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Conclusion</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>Expression
of activated <span class=SpellE>Ras</span> effector domain mutants that bind <span
class=SpellE>Raf</span>, PI3K, or <span class=SpellE>RalGEF</span> are
sufficient to induce the anchorage-independent growth of the human mammary
epithelial cell line HME16C and are associated with up-regulation of EGFR
ligands. However, only the ERK pathway is capable of supporting transformation
in the absence of EGFR signaling and of supporting tumorigenesis in nude mice.
Up-regulation of TDAG51 occurs during <span class=SpellE>Ras</span>-mediated
transformation in an ERK-dependent fashion, but opposes ERK-mediated transformation
by suppressing ERK signaling and decreasing cellular proliferation under
matrix-detached conditions. Therefore, in this model of mammary epithelial cell
transformation, TDAG51 acts as a growth inhibitor of ERK-driven proliferation
and may help explain why loss of TDAG51 expression has been found to correlate
with progression in human breast cancer and melanoma.</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/"
title="Go to other sections in this page"><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN'>Go to:</span></a></p>

<div style='border:none;border-bottom:solid #97B0C8 1.0pt;padding:0in 0in 0in 0in'>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:18.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Abbreviations</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>EGFR: epidermal
growth factor receptor; ErbB2: epidermal growth factor receptor family member
B2; <span class=SpellE>Erk</span>: extracellular regulated kinase; PHDLA1: <span
class=SpellE>pleckstrin</span> homology domain-like, family A, member 1; PI3K: <span
class=SpellE>phsphatidyl</span> inositol 3-kinase; PIK3CA: <span class=SpellE>phosphatidyl</span>
inositol 3-kinase, catalytic, alpha polypeptide; PTEN: phosphatase and <span
class=SpellE>tensin</span> homologue deleted from chromosome 10; <span
class=SpellE>Ral</span>: <span class=SpellE>ras</span>-like gene; <span
class=SpellE>RalGEF</span>: <span class=SpellE>Ral</span> guanidine nucleotide
exchange factor; <span class=SpellE>Rlf</span>: <span class=SpellE>RalGEF</span>-like
factor; shRNA: small hairpin ribonucleic acid; TDAG51: T-cell death associated
gene of 51 <span class=SpellE>kDa</span>.</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/"
title="Go to other sections in this page"><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN'>Go to:</span></a></p>

<div style='border:none;border-bottom:solid #97B0C8 1.0pt;padding:0in 0in 0in 0in'>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:18.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Competing interests</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>The authors
declare that they have no competing interests. The final text was reviewed and approved
by all the listed co-authors. They all contributed to the intellectual content
and to the experimental work in an honest manner. The contents have not been
published by or submitted to any other journal. No part of this text has been
included in any other paper.</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/"
title="Go to other sections in this page"><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN'>Go to:</span></a></p>

<div style='border:none;border-bottom:solid #97B0C8 1.0pt;padding:0in 0in 0in 0in'>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:18.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Authors' contributions</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>Conception
and design: MDO and KK. Provision of study materials: MDO, JJY, YW, and KK.
Collection and assembly of data: MDO, SJB, and LZ. Data analysis and
interpretation: MDO and KK. Manuscript writing: MDO and KK. Final approval of
manuscript: MDO, SJB, LZ, JJY, YW, and KK.</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/"
title="Go to other sections in this page"><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN'>Go to:</span></a></p>

<div style='border:none;border-bottom:solid #97B0C8 1.0pt;padding:0in 0in 0in 0in'>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:18.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Pre-publication history</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>The
pre-publication history for this paper can be accessed here:</span></p>

<p class=MsoNormal style='line-height:normal'><a
href="http://www.biomedcentral.com/1471-2407/8/189/prepub" target="pmc_ext"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>http://www.biomedcentral.com/1471-2407/8/189/prepub</span></a></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/"
title="Go to other sections in this page"><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN'>Go to:</span></a></p>

<div style='border:none;border-bottom:solid #97B0C8 1.0pt;padding:0in 0in 0in 0in'>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:18.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Supplementary Material</span></b></p>

</div>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><b><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>Additional file 1:</span></b></p>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Selected microarray data for HME16C cell lines</span></b><span lang=EN
style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>. The fold up-regulation or down-regulation of genes identified in
microarray analysis is indicated for genes where this value exceeded two-fold,
organized into categories according to broadly defined gene functions. PHLDA1
is categorized as an up-regulated gene under &quot;Miscellaneous.&quot;</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/bin/1471-2407-8-189-S1.doc"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>Click here for <span class=GramE>file</span></span></a><sup><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>(574K, doc)</span></sup></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><b><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>Additional file 2:</span></b></p>

<p class=MsoNormal style='line-height:normal'><span class=GramE><b><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>Real-time RT-PCR confirmation of selected microarray data</span></b><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>.</span></span><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN'> Results are for
transcripts identified as up- or down-regulated in microarray analysis of cDNA
from Ras<sup>V12</sup>-, Ras<sup>V12G37</sup>-, Ras<sup>V12S35</sup>-, Ras<sup>V12C40</sup>-,
and <span class=SpellE>Rlf</span>-CAAX-infected HME16C. Numbers represent fold
expression changes for transcript levels relative to vector-infected <span
class=SpellE>pLRT</span> control cells. Parenthetical numbers indicate mean
fold expression changes from cDNA microarray analysis (see Additional file
above). Sequences of primers used for real-time RT-PCR analysis are as follows:
<span class=SpellE>amphiregulin</span> Forward 5'-CGCCGGTGGTGCTGTCGCTCTT-3'
Reverse 5'-TCACTCACAGGGGAAATCTCACTC-3', anterior gradient 2 Forward
5'-GGGGTGACCAACTCATCTGGACTCAG-3' Reverse 5'-GACATACTGGCCATCAGGAGAAAGGTGT-3',
CD24 Forward 5'-GCTCCTACCCACGCAGATTTATT-3' Reverse
5'-CACGAAGAGACTGGCTGTTGACT-3', c-met Forward 5'-AAATGGCCACGGGACAACACAA-3'
Reverse 5'-TGGGCTGGGGTATAACATTCAAGA-3', CTGF Forward
5'-CTGCCCGGGAAATGCTGCGAGGAGT-3' Reverse 5'-CTGCAGGAGGCGTTGTCATTGGTAA-3', CYR61
Forward 5'-CGGCCCAAGTACTGCGGTTCCT-3' Reverse 5'-ATTGGCATGCGGGCAGTTGTAGTT-3', <span
class=SpellE>Decorin</span> Forward 5'-ACTTCTGCCCACCTGGACACAACA-3' Reverse
5'-ATGGCAGAGCGCACGTAGACACA-3', DICER-1 Forward 5'-CAGGAAATACCCGTGCAACCAACTA-3'
Reverse 5'-GCATTACGGCCATCACAGGACTTC-3', E-cadherin Forward
5'-GGTATCTTCCCCGCCCTGCCAATCC-3' Reverse 5'-AACCGCTTCCTTCATAGTCAAACACGAG-3',
EphA2 Forward 5'-CCCCTTCCGCCCCACACTACCTCACAGC-3' Reverse
5'-ACACGGCCCGCATTCCCCAGACTCG-3', <span class=SpellE>Epiregulin</span> Forward
5'-TTGTATTTTTAGTAGAGGCGGGGTTTCA-3' Reverse 5'-TCGGGCACAGATGTTCAAGTCAC-3', ETS-1
Forward 5'-ACTCGGGGGCCAGGACTCTTTTGAA-3' Reverse
5'-CACGGTCCCGCACATAGTCCTTGAA-3', ETS variant gene 5 Forward
5'-TCGGGGACGTCTACGGTTTCTACT-3' Reverse 5'-AAGACTGTAAACGGCTACCATTGA-3', FAT-2
Forward 5'-GCTGGACATCAAACGGGCTAACAT-3' Reverse 5'-ACCGCATCTGAACCCCCACTGAAT-3',
HMGA-1 Forward 5'-GCTCACCCTGCCCGCTCCCAACC-3' Reverse 5'-GCCCCAGCCCCTCTTCCCCACAAA-3',
HMGA-2 Forward 5'-CTGATAAGCAAGAGTGGGCGGGTGAGAA-3' Reverse
5'-ACAGGGAGTGGGTTGGGGTGGTATTTGA-3', Secreted frizzled-related protein 1 Forward
5'-CCCGCTCCCTTTCCCTCCATA-3' Reverse 5'-GCTCTCACTTTCCGCCCAATCC-3', Tenascin C
Forward 5'-GCGGCCCAGAGCGAGGAA-3' Reverse 5'-TATTGCGATGTTGTCACTGGGAGATTTT-3',
TGF-a Forward 5'-CCGCCTTGGTGGTGGTCTCC-3' Reverse 5'-AGGGCGCTGGGCTTCTCGTG-3',
TGF-&#946;2 Forward 5'-CCCGCCCACTTTCTACAGACCCTACT-3' Reverse
5'-CATTCGCCTTCTGCTCTTGTTTTCAC-3', TGF-&#946; receptor 2 Forward 5'-ACAGTGGCAGTCAAGATCTTTCCCTATG-3'
Reverse 5'-CAACTCCGTCTTCCGCTCCTCAG-3', TRIM29 Forward
5'-ATGCATGCGCCACGTTGAGAAGAT-3' Reverse 5'-GGTGAAGCGGCCAGGAGACGAG-3'.</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a
href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/bin/1471-2407-8-189-S2.doc"><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>Click here for <span class=GramE>file</span></span></a><sup><span
lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
mso-ansi-language:EN'>(50K, doc)</span></sup></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/"
title="Go to other sections in this page"><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN'>Go to:</span></a></p>

<div style='border:none;border-bottom:solid #97B0C8 1.0pt;padding:0in 0in 0in 0in'>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:18.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>Acknowledgements</span></b></p>

</div>

<p class=MsoNormal style='line-height:normal'><span lang=EN style='font-size:
12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:EN'>This
research was supported by the Intramural Research Program of the NIH, National
Cancer Institute, Center for Cancer Research.</span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474852/"
title="Go to other sections in this page"><span lang=EN style='font-size:12.0pt;
font-family:"Times New Roman","serif";mso-ansi-language:EN'>Go to:</span></a></p>

<div style='border:none;border-bottom:solid #97B0C8 1.0pt;padding:0in 0in 0in 0in'>

<p class=MsoNormal style='line-height:normal'><b><span lang=EN
style='font-size:18.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
EN'>References</span></b></p>

</div>

<ol style='margin-top:0in' start=1 type=1>
 <li class=MsoNormal style='line-height:normal;mso-list:l0 level1 lfo1;
     tab-stops:list .5in'><span class=GramE><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>van 't</span></span><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'> Veer LJ, Dai H, <span class=SpellE>Vijver</span> MJ
     van de, He YD, Hart AA, Mao M, <span class=SpellE>Peterse</span> HL, <span
     class=SpellE>Kooy</span> K van der, <span class=SpellE>Marton</span> MJ, <span
     class=SpellE>Witteveen</span> AT, et al. Gene expression profiling
     predicts clinical outcome of breast cancer. Nature. 2002<span class=GramE>;415:530</span>�536.
     <span class=SpellE><span class=GramE>doi</span></span>: 10.1038/415530a. [</span><span
     style='mso-fareast-font-family:"Times New Roman"'><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/11823860" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>PubMed</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>] [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a href="http://dx.doi.org/10.1038%2F415530a"
     target="pmc_ext"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>Cross Ref</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>]</span><span style='mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l0 level1 lfo1;
     tab-stops:list .5in'><span class=SpellE><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Bos</span></span><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'> JL. <span class=SpellE><span class=GramE>ras</span></span>
     oncogenes in human cancer: a review. Cancer Res. 1989<span class=GramE>;49:4682</span>�4689.
     [</span><span style='mso-fareast-font-family:"Times New Roman"'><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/2547513" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>PubMed</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>]</span><span style='mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l0 level1 lfo1;
     tab-stops:list .5in'><span class=SpellE><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Malaney</span></span><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'> S, Daly RJ. The <span class=SpellE>ras</span> signaling
     pathway in mammary tumorigenesis and metastasis. J Mammary Gland <span
     class=SpellE>Biol</span> Neoplasia. 2001<span class=GramE>;6:101</span>�113.
     <span class=SpellE><span class=GramE>doi</span></span>:
     10.1023/A:1009572700317. [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a href="http://www.ncbi.nlm.nih.gov/pubmed/11467446"
     target="pmc_ext"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>PubMed</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>] [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a href="http://dx.doi.org/10.1023%2FA%3A1009572700317"
     target="pmc_ext"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>Cross Ref</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>]</span><span style='mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l0 level1 lfo1;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Mueller H, <span class=SpellE>Flury</span> N, <span
     class=SpellE>Eppenberger-Castori</span> S, <span class=SpellE>Kueng</span>
     W, David F, <span class=SpellE>Eppenberger</span> U. Potential prognostic
     value of mitogen-activated protein kinase activity for disease-free
     survival of primary breast cancer patients. <span class=SpellE>Int</span>
     J Cancer. 2000<span class=GramE>;89:384</span>�388. <span class=SpellE>doi</span>:
     10.1002/1097-0215(20000720)89:4&lt;384::AID-IJC11&gt;3.0.CO;2-R. [</span><span
     style='mso-fareast-font-family:"Times New Roman"'><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/10956414" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>PubMed</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>] [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a
     href="http://dx.doi.org/10.1002%2F1097-0215(20000720)89%3A4%3C384%3A%3AAID-IJC11%3E3.0.CO%3B2-R"
     target="pmc_ext"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>Cross Ref</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>]</span><span style='mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l0 level1 lfo1;
     tab-stops:list .5in'><span class=SpellE><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Abd</span></span><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'> El-<span class=SpellE>Rehim</span> DM, <span
     class=SpellE>Pinder</span> SE, <span class=SpellE>Paish</span> CE, Bell
     JA, <span class=SpellE>Rampaul</span> RS, Blamey RW, Robertson JF,
     Nicholson RI, Ellis IO. Expression and co-expression of the members of the
     epidermal growth factor receptor (EGFR) family in invasive breast
     carcinoma. Br J Cancer. 2004<span class=GramE>;91:1532</span>�1542. <span
     class=SpellE><span class=GramE>doi</span></span>: 10.1038/sj.bjc.6602184.
     [</span><span style='mso-fareast-font-family:"Times New Roman"'><a
     href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410019/"><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
     EN'>PMC free article</span></a></span><span lang=EN style='font-size:12.0pt;
     font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>] [</span><span style='mso-fareast-font-family:"Times New Roman"'><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/15480434" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>PubMed</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>] [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a href="http://dx.doi.org/10.1038%2Fsj.bjc.6602184"
     target="pmc_ext"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>Cross Ref</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>]</span><span style='mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l0 level1 lfo1;
     tab-stops:list .5in'><span class=SpellE><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Sapi</span></span><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'> E. The role of CSF-1 in normal physiology of
     mammary gland and breast cancer: an update. <span class=SpellE>Exp</span> <span
     class=SpellE>Biol</span> Med (Maywood) 2004<span class=GramE>;229:1</span>�11.
     [</span><span style='mso-fareast-font-family:"Times New Roman"'><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/14709771" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>PubMed</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>]</span><span style='mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l0 level1 lfo1;
     tab-stops:list .5in'><span class=SpellE><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Slamon</span></span><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'> DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire
     WL. Human breast cancer: correlation of relapse and survival with
     amplification of the HER-2/<span class=SpellE>neu</span> oncogene.
     Science. 1987<span class=GramE>;235:177</span>�182. <span class=SpellE><span
     class=GramE>doi</span></span>: 10.1126/science.3798106. [</span><span
     style='mso-fareast-font-family:"Times New Roman"'><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/3798106" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>PubMed</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>] [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a href="http://dx.doi.org/10.1126%2Fscience.3798106"
     target="pmc_ext"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>Cross Ref</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>]</span><span style='mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l0 level1 lfo1;
     tab-stops:list .5in'><span class=SpellE><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Normanno</span></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'> N, Bianco C, De Luca A, Salomon
     DS. The role of EGF-related peptides in tumor growth. Front <span
     class=SpellE>Biosci</span>. 2001<span class=GramE>;6:D685</span>�707. <span
     class=SpellE><span class=GramE>doi</span></span>: 10.2741/<span
     class=SpellE>Normano</span>. [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a href="http://www.ncbi.nlm.nih.gov/pubmed/11333208"
     target="pmc_ext"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>PubMed</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>] [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a href="http://dx.doi.org/10.2741%2FNormano"
     target="pmc_ext"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>Cross Ref</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>]</span><span style='mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l0 level1 lfo1;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Bachman KE, <span class=SpellE>Argani</span> P,
     Samuels Y, Silliman N, <span class=SpellE>Ptak</span> J, Szabo S, <span
     class=SpellE>Konishi</span> H, Karakas B, Blair BG, Lin C, et al. The
     PIK3CA gene is mutated with high frequency in human breast cancers. Cancer
     <span class=SpellE>Biol</span> <span class=SpellE>Ther</span>. 2004<span
     class=GramE>;3:772</span>�775. [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a href="http://www.ncbi.nlm.nih.gov/pubmed/15254419"
     target="pmc_ext"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>PubMed</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>]</span><span style='mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l0 level1 lfo1;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Perez-<span class=SpellE>Tenorio</span> G, <span
     class=SpellE>Alkhori</span> L, Olsson B, <span class=SpellE>Waltersson</span>
     MA, Nordenskjold B, <span class=SpellE>Rutqvist</span> LE, Skoog L, <span
     class=SpellE>Stal</span> O. PIK3CA mutations and PTEN loss correlate with
     similar prognostic factors and are not mutually exclusive in breast cancer.
     <span class=SpellE>Clin</span> Cancer Res. 2007<span class=GramE>;13:3577</span>�3584.
     <span class=SpellE><span class=GramE>doi</span></span>:
     10.1158/1078-0432.CCR-06-1609. [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a href="http://www.ncbi.nlm.nih.gov/pubmed/17575221"
     target="pmc_ext"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>PubMed</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>] [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a
     href="http://dx.doi.org/10.1158%2F1078-0432.CCR-06-1609" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>Cross Ref</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>]</span><span style='mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l0 level1 lfo1;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Rodriguez-<span class=SpellE>Viciana</span> P,
     Sabatier C, <span class=GramE>McCormick</span> F. Signaling specificity by
     <span class=SpellE>Ras</span> family <span class=SpellE>GTPases</span> is
     determined by the full spectrum of effectors they regulate. <span
     class=SpellE>Mol</span> Cell Biol. 2004<span class=GramE>;24:4943</span>�4954.
     <span class=SpellE><span class=GramE>doi</span></span>:
     10.1128/MCB.24.11.4943-4954.2004. [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a
     href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC416418/"><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
     EN'>PMC free article</span></a></span><span lang=EN style='font-size:12.0pt;
     font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>] [</span><span style='mso-fareast-font-family:"Times New Roman"'><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/15143186" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>PubMed</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>] [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a
     href="http://dx.doi.org/10.1128%2FMCB.24.11.4943-4954.2004"
     target="pmc_ext"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>Cross Ref</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>]</span><span style='mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l0 level1 lfo1;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>White MA, Nicolette C, Minden A, <span class=SpellE>Polverino</span>
     A, Van <span class=SpellE>Aelst</span> L, Karin M, <span class=SpellE>Wigler</span>
     MH. Multiple <span class=SpellE>Ras</span> functions can contribute to
     mammalian cell transformation. Cell. 1995<span class=GramE>;80:533</span>�541.
     <span class=SpellE><span class=GramE>doi</span></span>:
     10.1016/0092-8674(95)90507-3. [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a href="http://www.ncbi.nlm.nih.gov/pubmed/7867061"
     target="pmc_ext"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>PubMed</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>] [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a
     href="http://dx.doi.org/10.1016%2F0092-8674(95)90507-3" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>Cross Ref</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>]</span><span style='mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l0 level1 lfo1;
     tab-stops:list .5in'><span class=SpellE><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Janda</span></span><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'> E, Lehmann K, <span class=SpellE>Killisch</span> I,
     <span class=SpellE>Jechlinger</span> M, <span class=SpellE>Herzig</span>
     M, Downward J, <span class=SpellE>Beug</span> H, <span class=SpellE>Grunert</span>
     S. <span class=SpellE>Ras</span> and <span class=GramE>TGF[</span>beta]
     cooperatively regulate epithelial cell plasticity and metastasis:
     dissection of <span class=SpellE>Ras</span> signaling pathways. J Cell
     Biol. 2002<span class=GramE>;156:299</span>�313. <span class=SpellE><span
     class=GramE>doi</span></span>: 10.1083/jcb.200109037. [</span><span
     style='mso-fareast-font-family:"Times New Roman"'><a
     href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2199233/"><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
     EN'>PMC free article</span></a></span><span lang=EN style='font-size:12.0pt;
     font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>] [</span><span style='mso-fareast-font-family:"Times New Roman"'><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/11790801" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>PubMed</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>] [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a href="http://dx.doi.org/10.1083%2Fjcb.200109037"
     target="pmc_ext"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>Cross Ref</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>]</span><span style='mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l0 level1 lfo1;
     tab-stops:list .5in'><span class=SpellE><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Rangarajan</span></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'> A, Hong SJ, Gifford A, Weinberg
     RA. Species- and cell type-specific requirements for cellular
     transformation. Cancer Cell. 2004<span class=GramE>;6:171</span>�183. <span
     class=SpellE><span class=GramE>doi</span></span>:
     10.1016/j.ccr.2004.07.009. [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a href="http://www.ncbi.nlm.nih.gov/pubmed/15324700"
     target="pmc_ext"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>PubMed</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>] [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a href="http://dx.doi.org/10.1016%2Fj.ccr.2004.07.009"
     target="pmc_ext"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>Cross Ref</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>]</span><span style='mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l0 level1 lfo1;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Zhao JJ, <span class=SpellE>Gjoerup</span> OV,
     Subramanian RR, Cheng Y, Chen W, Roberts TM, Hahn WC. Human mammary
     epithelial cell transformation through the activation of
     phosphatidylinositol 3-kinase. Cancer Cell. 2003<span class=GramE>;3:483</span>�495.
     <span class=SpellE><span class=GramE>doi</span></span>:
     10.1016/S1535-6108(03)00088-6. [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a href="http://www.ncbi.nlm.nih.gov/pubmed/12781366"
     target="pmc_ext"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>PubMed</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>] [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a
     href="http://dx.doi.org/10.1016%2FS1535-6108(03)00088-6" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>Cross Ref</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>]</span><span style='mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l0 level1 lfo1;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Schulze A, Lehmann K, Jefferies HB, McMahon M,
     Downward J. Analysis of the transcriptional program induced by <span
     class=SpellE>Raf</span> in epithelial cells. Genes Dev. 2001<span
     class=GramE>;15:981</span>�994. <span class=SpellE><span class=GramE>doi</span></span>:
     10.1101/gad.191101. [</span><span style='mso-fareast-font-family:"Times New Roman"'><a
     href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC312671/"><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
     EN'>PMC free article</span></a></span><span lang=EN style='font-size:12.0pt;
     font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>] [</span><span style='mso-fareast-font-family:"Times New Roman"'><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/11316792" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>PubMed</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>] [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a href="http://dx.doi.org/10.1101%2Fgad.191101"
     target="pmc_ext"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>Cross Ref</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>]</span><span style='mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l0 level1 lfo1;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Nagai MA, <span class=SpellE>Fregnani</span> JH, <span
     class=SpellE>Netto</span> MM, Brentani MM, <span class=SpellE>Soares</span>
     FA. Down-regulation of PHLDA1 gene expression is associated with breast
     cancer progression. Breast Cancer Res Treat. 2007<span class=GramE>;106:49</span>�56.
     <span class=SpellE><span class=GramE>doi</span></span>:
     10.1007/s10549-006-9475-6. [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a href="http://www.ncbi.nlm.nih.gov/pubmed/17211533"
     target="pmc_ext"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>PubMed</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>] [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a href="http://dx.doi.org/10.1007%2Fs10549-006-9475-6"
     target="pmc_ext"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>Cross Ref</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>]</span><span style='mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l0 level1 lfo1;
     tab-stops:list .5in'><span class=SpellE><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Neef</span></span><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'> R, <span class=SpellE>Kuske</span> MA, <span
     class=SpellE>Prols</span> E, Johnson JP. Identification of the human
     PHLDA1/TDAG51 gene: down-regulation in metastatic melanoma contributes to
     apoptosis resistance and growth deregulation. Cancer Res. 2002<span
     class=GramE>;62:5920</span>�5929. [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a href="http://www.ncbi.nlm.nih.gov/pubmed/12384558"
     target="pmc_ext"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>PubMed</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>]</span><span style='mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l0 level1 lfo1;
     tab-stops:list .5in'><span class=SpellE><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Haegen</span></span><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'> BA Van der, Shay JW. Immortalization of human
     mammary epithelial cells by SV40 large T-antigen involves a <span
     class=SpellE>two step</span> mechanism. In Vitro Cell Dev Biol. 1993<span
     class=GramE>;29A:180</span>�182. <span class=SpellE><span class=GramE>doi</span></span>:
     10.1007/BF02634177. [</span><span style='mso-fareast-font-family:"Times New Roman"'><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/8463179" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>PubMed</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>] [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a href="http://dx.doi.org/10.1007%2FBF02634177"
     target="pmc_ext"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>Cross Ref</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>]</span><span style='mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l0 level1 lfo1;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Hahn WC, Counter CM, Lundberg AS, <span
     class=SpellE>Beijersbergen</span> RL, Brooks MW, Weinberg RA. Creation of
     human <span class=SpellE>tumour</span> cells with defined genetic
     elements. Nature. 1999<span class=GramE>;400:464</span>�468. <span
     class=SpellE><span class=GramE>doi</span></span>: 10.1038/22780. [</span><span
     style='mso-fareast-font-family:"Times New Roman"'><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/10440377" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>PubMed</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>] [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a href="http://dx.doi.org/10.1038%2F22780"
     target="pmc_ext"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>Cross Ref</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>]</span><span style='mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l0 level1 lfo1;
     tab-stops:list .5in'><span class=SpellE><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Wolthuis</span></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'> RM, de <span class=SpellE>Ruiter</span>
     ND, Cool RH, <span class=SpellE>Bos</span> JL. Stimulation of gene
     induction and cell growth by the <span class=SpellE>Ras</span> effector <span
     class=SpellE>Rlf</span>. <span class=SpellE>Embo</span> J. 1997<span
     class=GramE>;16:6748</span>�6761. <span class=SpellE><span class=GramE>doi</span></span>:
     10.1093/<span class=SpellE>emboj</span>/16.22.6748. [</span><span
     style='mso-fareast-font-family:"Times New Roman"'><a
     href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1170279/"><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
     EN'>PMC free article</span></a></span><span lang=EN style='font-size:12.0pt;
     font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>] [</span><span style='mso-fareast-font-family:"Times New Roman"'><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/9362489" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>PubMed</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>] [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a href="http://dx.doi.org/10.1093%2Femboj%2F16.22.6748"
     target="pmc_ext"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>Cross Ref</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>]</span><span style='mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l0 level1 lfo1;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Leaner VD, Kinoshita I, <span class=SpellE>Birrer</span>
     MJ. AP-1 complexes containing <span class=SpellE>cJun</span> and <span
     class=SpellE>JunB</span> cause cellular transformation of Rat1a
     fibroblasts and share transcriptional targets. Oncogene. 2003<span
     class=GramE>;22:5619</span>�5629. <span class=SpellE><span class=GramE>doi</span></span>:
     10.1038/sj.onc.1206644. [</span><span style='mso-fareast-font-family:"Times New Roman"'><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/12944910" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>PubMed</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>] [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a href="http://dx.doi.org/10.1038%2Fsj.onc.1206644"
     target="pmc_ext"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>Cross Ref</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>]</span><span style='mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l0 level1 lfo1;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Yin J, Pollock C, Tracy K, Chock M, Martin P, <span
     class=SpellE>Oberst</span> M, <span class=GramE>Kelly</span> K. Activation
     of the <span class=SpellE>RalGEF</span>/<span class=SpellE>Ral</span>
     pathway promotes prostate cancer metastasis to bone. <span class=SpellE>Mol</span>
     Cell Biol. 2007<span class=GramE>;27:7538</span>�7550. <span class=SpellE><span
     class=GramE>doi</span></span>: 10.1128/MCB.00955-07. [</span><span
     style='mso-fareast-font-family:"Times New Roman"'><a
     href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2169046/"><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
     EN'>PMC free article</span></a></span><span lang=EN style='font-size:12.0pt;
     font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>] [</span><span style='mso-fareast-font-family:"Times New Roman"'><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/17709381" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>PubMed</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>] [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a href="http://dx.doi.org/10.1128%2FMCB.00955-07"
     target="pmc_ext"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>Cross Ref</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>]</span><span style='mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l0 level1 lfo1;
     tab-stops:list .5in'><span class=SpellE><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Zufferey</span></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'> R, Dull T, Mandel RJ, <span
     class=SpellE>Bukovsky</span> A, Quiroz D, <span class=SpellE>Naldini</span>
     L, <span class=SpellE>Trono</span> D. Self-inactivating lentivirus vector
     for safe and efficient in vivo gene delivery. J <span class=SpellE>Virol</span>.
     1998<span class=GramE>;72:9873</span>�9880. [</span><span
     style='mso-fareast-font-family:"Times New Roman"'><a
     href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC110499/"><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
     EN'>PMC free article</span></a></span><span lang=EN style='font-size:12.0pt;
     font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>] [</span><span style='mso-fareast-font-family:"Times New Roman"'><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/9811723" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>PubMed</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>]</span><span style='mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l0 level1 lfo1;
     tab-stops:list .5in'><span style='mso-fareast-font-family:"Times New Roman"'><a
     href="http://nciarray.nci.nih.gov/" target="pmc_ext"><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
     EN'>http://nciarray.nci.nih.gov/</span></a><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l0 level1 lfo1;
     tab-stops:list .5in'><span style='mso-fareast-font-family:"Times New Roman"'><a
     href="http://www.ncbi.nlm.nih.gov/geo" target="pmc_ext"><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
     EN'>http://www.ncbi.nlm.nih.gov/geo</span></a><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l0 level1 lfo1;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Hamad NM, <span class=SpellE>Elconin</span> JH, <span
     class=SpellE>Karnoub</span> AE, Bai W, Rich JN, Abraham RT, Der CJ,
     Counter CM. Distinct requirements for <span class=SpellE>Ras</span>
     oncogenesis in human versus mouse cells. Genes Dev. 2002<span class=GramE>;16:2045</span>�2057.
     <span class=SpellE><span class=GramE>doi</span></span>:
     10.1101/gad.993902. [</span><span style='mso-fareast-font-family:"Times New Roman"'><a
     href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC186434/"><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
     EN'>PMC free article</span></a></span><span lang=EN style='font-size:12.0pt;
     font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>] [</span><span style='mso-fareast-font-family:"Times New Roman"'><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/12183360" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>PubMed</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>] [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a href="http://dx.doi.org/10.1101%2Fgad.993902"
     target="pmc_ext"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>Cross Ref</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>]</span><span style='mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l0 level1 lfo1;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Fry DW, <span class=SpellE>Kraker</span> AJ,
     McMichael A, <span class=SpellE>Ambroso</span> LA, Nelson JM, Leopold WR,
     Connors RW, Bridges AJ. A specific inhibitor of the epidermal growth
     factor receptor tyrosine kinase. Science. 1994<span class=GramE>;265:1093</span>�1095.
     <span class=SpellE><span class=GramE>doi</span></span>: 10.1126/science.8066447.
     [</span><span style='mso-fareast-font-family:"Times New Roman"'><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/8066447" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>PubMed</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>] [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a href="http://dx.doi.org/10.1126%2Fscience.8066447"
     target="pmc_ext"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>Cross Ref</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>]</span><span style='mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l0 level1 lfo1;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Fry DW, Bridges AJ, Denny WA, Doherty A, <span
     class=SpellE>Greis</span> KD, Hicks JL, Hook KE, Keller PR, Leopold WR,
     Loo JA, et al. Specific, irreversible inactivation of the epidermal growth
     factor receptor and erbB2, by a new class of tyrosine kinase inhibitor.
     Proc Natl <span class=SpellE>Acad</span> <span class=SpellE>Sci</span>
     USA. 1998<span class=GramE>;95:12022</span>�12027. <span class=SpellE><span
     class=GramE>doi</span></span>: 10.1073/pnas.95.20.12022. [</span><span
     style='mso-fareast-font-family:"Times New Roman"'><a
     href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC21758/"><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
     EN'>PMC free article</span></a></span><span lang=EN style='font-size:12.0pt;
     font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>] [</span><span style='mso-fareast-font-family:"Times New Roman"'><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/9751783" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>PubMed</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>] [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a href="http://dx.doi.org/10.1073%2Fpnas.95.20.12022"
     target="pmc_ext"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>Cross Ref</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>]</span><span style='mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l0 level1 lfo1;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Schulze A, <span class=SpellE>Nicke</span> B, Warne
     PH, Tomlinson S, Downward J. The transcriptional response to <span
     class=SpellE><span class=GramE>Raf</span></span> activation is almost
     completely dependent on Mitogen-activated Protein Kinase <span
     class=SpellE>Kinase</span> activity and shows a major autocrine component.
     <span class=SpellE>Mol</span> <span class=SpellE>Biol</span> Cell. 2004<span
     class=GramE>;15:3450</span>�3463. <span class=SpellE><span class=GramE>doi</span></span>:
     10.1091/mbc.E03-11-0807. [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a
     href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC452596/"><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
     EN'>PMC free article</span></a></span><span lang=EN style='font-size:12.0pt;
     font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>] [</span><span style='mso-fareast-font-family:"Times New Roman"'><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/15090615" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>PubMed</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>] [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a href="http://dx.doi.org/10.1091%2Fmbc.E03-11-0807"
     target="pmc_ext"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>Cross Ref</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>]</span><span style='mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l0 level1 lfo1;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Davies SP, Reddy H, <span class=SpellE>Caivano</span>
     M, Cohen P. Specificity and mechanism of action of some commonly used
     protein kinase inhibitors. <span class=SpellE>Biochem</span> J. 2000<span
     class=GramE>;351:95</span>�105. <span class=SpellE><span class=GramE>doi</span></span>:
     10.1042/0264-6021:3510095. [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a
     href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1221339/"><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
     EN'>PMC free article</span></a></span><span lang=EN style='font-size:12.0pt;
     font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>] [</span><span style='mso-fareast-font-family:"Times New Roman"'><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/10998351" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>PubMed</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>] [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a
     href="http://dx.doi.org/10.1042%2F0264-6021%3A3510095" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>Cross Ref</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>]</span><span style='mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l0 level1 lfo1;
     tab-stops:list .5in'><span class=SpellE><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Ince</span></span><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'> TA, Richardson AL, Bell GW, <span class=SpellE>Saitoh</span>
     M, <span class=SpellE>Godar</span> S, <span class=SpellE>Karnoub</span>
     AE, <span class=SpellE>Iglehart</span> JD, Weinberg RA. Transformation of
     different human breast epithelial cell types leads to distinct tumor
     phenotypes. Cancer Cell. 2007<span class=GramE>;12:160</span>�170. <span
     class=SpellE><span class=GramE>doi</span></span>:
     10.1016/j.ccr.2007.06.013. [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a href="http://www.ncbi.nlm.nih.gov/pubmed/17692807"
     target="pmc_ext"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>PubMed</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>] [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a href="http://dx.doi.org/10.1016%2Fj.ccr.2007.06.013"
     target="pmc_ext"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>Cross Ref</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>]</span><span style='mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l0 level1 lfo1;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Frank D, Mendelsohn CL, Ciccone E, <span
     class=SpellE>Svensson</span> K, <span class=SpellE>Ohlsson</span> R, <span
     class=SpellE>Tycko</span> B. A novel <span class=SpellE>pleckstrin</span>
     homology-related gene family defined by <span class=SpellE>Ipl</span>/Tssc3,
     TDAG51, and Tih1: tissue-specific expression, chromosomal location, and
     parental imprinting. <span class=SpellE>Mamm</span> Genome. 1999<span
     class=GramE>;10:1150</span>�1159. <span class=SpellE><span class=GramE>doi</span></span>:
     10.1007/s003359901182. [</span><span style='mso-fareast-font-family:"Times New Roman"'><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/10594239" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>PubMed</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>] [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a href="http://dx.doi.org/10.1007%2Fs003359901182"
     target="pmc_ext"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>Cross Ref</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>]</span><span style='mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l0 level1 lfo1;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Gomes I, <span class=SpellE>Xiong</span> W, Miki T, <span
     class=SpellE><span class=GramE>Rosner</span></span> MR. A proline- and
     glutamine-rich protein promotes apoptosis in neuronal cells. J <span
     class=SpellE>Neurochem</span>. 1999<span class=GramE>;73:612</span>�622. <span
     class=SpellE><span class=GramE>doi</span></span>:
     10.1046/j.1471-4159.1999.0730612.x. [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a href="http://www.ncbi.nlm.nih.gov/pubmed/10428057"
     target="pmc_ext"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>PubMed</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>] [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a
     href="http://dx.doi.org/10.1046%2Fj.1471-4159.1999.0730612.x"
     target="pmc_ext"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>Cross Ref</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>]</span><span style='mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l0 level1 lfo1;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Park CG, Lee SY, <span class=SpellE>Kandala</span>
     G, Lee SY, Choi Y. A novel gene product that couples TCR signaling to <span
     class=SpellE><span class=GramE>Fas</span></span><span class=GramE>(</span>CD95)
     expression in activation-induced cell death. Immunity. 1996<span
     class=GramE>;4:583</span>�591. <span class=SpellE><span class=GramE>doi</span></span>:
     10.1016/S1074-7613(00)80484-7. [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a href="http://www.ncbi.nlm.nih.gov/pubmed/8673705"
     target="pmc_ext"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>PubMed</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>] [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a
     href="http://dx.doi.org/10.1016%2FS1074-7613(00)80484-7" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>Cross Ref</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>]</span><span style='mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l0 level1 lfo1;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Toyoshima Y, <span class=SpellE>Karas</span> M, <span
     class=SpellE>Yakar</span> S, <span class=SpellE>Dupont</span> J, Lee H, <span
     class=SpellE>LeRoith</span> D. TDAG51 mediates the effects of insulin-like
     growth factor I (IGF-I) on cell survival. J <span class=SpellE>Biol</span>
     Chem. 2004<span class=GramE>;279:25898</span>�25904. <span class=SpellE><span
     class=GramE>doi</span></span>: 10.1074/jbc.M400661200. [</span><span
     style='mso-fareast-font-family:"Times New Roman"'><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/15037619" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>PubMed</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>] [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a href="http://dx.doi.org/10.1074%2Fjbc.M400661200"
     target="pmc_ext"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>Cross Ref</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>]</span><span style='mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l0 level1 lfo1;
     tab-stops:list .5in'><span class=SpellE><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Hayashida</span></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'> N, Inouye S, Fujimoto M, Tanaka
     Y, <span class=SpellE>Izu</span> H, <span class=SpellE>Takaki</span> E,
     Ichikawa H, Rho J, <span class=SpellE>Nakai</span> A. A novel
     HSF1-mediated death pathway that is suppressed by heat shock proteins. <span
     class=SpellE>Embo</span> J. 2006<span class=GramE>;25:4773</span>�4783. <span
     class=SpellE><span class=GramE>doi</span></span>:
     10.1038/sj.emboj.7601370. [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a
     href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1618102/"><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-ansi-language:
     EN'>PMC free article</span></a></span><span lang=EN style='font-size:12.0pt;
     font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>] [</span><span style='mso-fareast-font-family:"Times New Roman"'><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/17024176" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>PubMed</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>] [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a href="http://dx.doi.org/10.1038%2Fsj.emboj.7601370"
     target="pmc_ext"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>Cross Ref</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>]</span><span style='mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l0 level1 lfo1;
     tab-stops:list .5in'><span lang=EN style='font-size:12.0pt;font-family:
     "Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Hossain GS, van <span class=SpellE>Thienen</span>
     JV, <span class=SpellE>Werstuck</span> GH, Zhou J, <span class=SpellE>Sood</span>
     SK, <span class=SpellE>Dickhout</span> JG, de <span class=SpellE>Koning</span>
     AB, Tang D, Wu D, Falk E, et al. TDAG51 is induced by homocysteine,
     promotes detachment-mediated programmed cell death, and contributes to the
     <span class=SpellE>cevelopment</span> of atherosclerosis in <span
     class=SpellE>hyperhomocysteinemia</span>. J <span class=SpellE>Biol</span>
     Chem. 2003<span class=GramE>;278:30317</span>�30327. <span class=SpellE><span
     class=GramE>doi</span></span>: 10.1074/jbc.M212897200. [</span><span
     style='mso-fareast-font-family:"Times New Roman"'><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/12738777" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>PubMed</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>] [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a href="http://dx.doi.org/10.1074%2Fjbc.M212897200"
     target="pmc_ext"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>Cross Ref</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>]</span><span style='mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l0 level1 lfo1;
     tab-stops:list .5in'><span class=SpellE><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Joo</span></span><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'> JH, Liao G, Collins JB, Grissom SF, <span
     class=SpellE>Jetten</span> AM. <span class=SpellE>Farnesol</span>-induced
     apoptosis in human lung carcinoma cells is coupled to the endoplasmic
     reticulum stress response. Cancer Res. 2007<span class=GramE>;67:7929</span>�7936.
     <span class=SpellE><span class=GramE>doi</span></span>:
     10.1158/0008-5472.CAN-07-0931. [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a href="http://www.ncbi.nlm.nih.gov/pubmed/17699800"
     target="pmc_ext"><span lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>PubMed</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>] [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a
     href="http://dx.doi.org/10.1158%2F0008-5472.CAN-07-0931" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>Cross Ref</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>]</span><span style='mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
 <li class=MsoNormal style='line-height:normal;mso-list:l0 level1 lfo1;
     tab-stops:list .5in'><span class=SpellE><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'>Hinz</span></span><span lang=EN style='font-size:
     12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:"Times New Roman";
     mso-ansi-language:EN'> T, <span class=SpellE>Flindt</span> S, Marx A,
     Janssen O, <span class=SpellE>Kabelitz</span> D. Inhibition of protein
     synthesis by the T cell receptor-inducible human TDAG51 gene product. Cell
     Signal. 2001<span class=GramE>;13:345</span>�352. <span class=SpellE><span
     class=GramE>doi</span></span>: 10.1016/S0898-6568(01)00141-3. [</span><span
     style='mso-fareast-font-family:"Times New Roman"'><a
     href="http://www.ncbi.nlm.nih.gov/pubmed/11369516" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>PubMed</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>] [</span><span style='mso-fareast-font-family:
     "Times New Roman"'><a
     href="http://dx.doi.org/10.1016%2FS0898-6568(01)00141-3" target="pmc_ext"><span
     lang=EN style='font-size:12.0pt;font-family:"Times New Roman","serif";
     mso-ansi-language:EN'>Cross Ref</span></a></span><span lang=EN
     style='font-size:12.0pt;font-family:"Times New Roman","serif";mso-fareast-font-family:
     "Times New Roman";mso-ansi-language:EN'>]</span><span style='mso-fareast-font-family:
     "Times New Roman"'><o:p></o:p></span></li>
</ol>

<p class=MsoNormal>&nbsp;</p>

</div>

</body>

</html>
